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resumo 
 
 
A amamentação é o modo ideal de nutrir os bebés. Estimula o sistema 
imunitário, a digestão e absorção dos nutrientes, a função gastrointestinal e o 
desenvolvimento neurológico do bebé. A composição do leite materno varia ao 
longo do ciclo de lactação, sendo que o colostro – primeira secreção da 
glândula mamária – é mais rico em nutrientes e anticorpos. O leite materno 
apresenta benefícios imunológicos e nutricionais acrescidos relativamente às 
fórmulas infantis à base de leite de vaca. Assim, quando uma mãe não pode 
amamentar, o leite de outras mães (dadoras) é a alternativa mais adequada, 
existindo bancos de leite humano em vários países para este fim. Nestes 
bancos, o leite é comummente pasteurizado pelo método Holder (62.5 ºC 
durante 30 min), de modo a garantir a sua segurança microbiológica. No 
entanto, esta pasteurização lenta resulta em diversas perdas nutricionais e 
funcionais. Como tal, este leite pasteurizado tem de ser suplementado com 
multi-nutrientes. A alta pressão (AP) é uma tecnologia cada vez mais usada na 
indústria alimentar, uma vez que permite pasteurizar os alimentos à 
temperatura ambiente ou mesmo a frio, garantindo a sua segurança 
microbiológica com manutenção das propriedades nutricionais e funcionais. 
Este trabalho teve como objetivo primordial avaliar e comparar o efeito da 
pasteurização Holder e da AP (200, 400 e 600 MPa durante 2.5, 15 e 30 min a 
8 ºC) na concentração das imunoglobulinas A, M e G, e na atividade das 
enzimas lisozima e lactoperoxidase do leite e colostro humanos. Observou-se 
que tratamentos de AP a 200 e 400 MPa não causaram diminuções 
significativas em todas as Igs e na lisozima (p>0.05). A pasteurização, por sua 
vez, resultou em perdas significativas destas proteínas antimicrobianas. Não 
foi detetada atividade da enzima lactoperoxidase. No caso do leite humano, 
também o efeito combinado da AP com alta temperatura (500, 700 e 900 MPa 
a 40, 60 e 80 ºC durante 15 min) na atividade da lisozima foi testado, tendo-se 
verificado um aumento na atividade após 500, 700 e 900 MPa a 40 ºC e a 
inativação da enzima a 80 ºC. Além disto, é apresentada uma revisão 
detalhada da literatura acerca da composição do leite humano, bancos de leite 
e efeitos da pasteurização Holder, tecnologia de AP e efeito da mesma no 
referido leite. 
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abstract 
 
Breastfeeding is the ideal nutrition for infants. It enhances host defences, 
digestion and absorption of nutrients, gastrointestinal function, and neurological 
development. Breast milk composition varies widely along lactation, and 
colostrum – first secretion of the mammary gland – is richer in nutrients and 
immunoglobulins (Igs). Human milk is a better alternative than bovine milk-
based infant formulas, due to its unique immunological and nutritional profile. 
Therefore, when the mother cannot breastfeed, the breast milk of other 
mothers (donors) is the most adequate alternative. There are human milk 
banks in several countries for this purpose, which commonly pasteurise the 
milk by the Holder pasteurisation method (62.5 ºC for 30 min), in order to 
assure its microbial safety. However, this low-temperature long-time 
pasteurisation results in various nutritional and functional losses. Thus, this 
pasteurised milk has to be supplemented with multi-nutrients. High-pressure 
processing (HPP) is a processing technology that is being increasingly applied 
in the food industry, since it allows pasteurisation of foods at room temperature 
or even at refrigeration temperature, guarantying microbial inactivation while 
maintaining its nutritional and functional properties. 
The main goal of this work was to investigate and compare the effect of Holder 
pasteurisation and HPP (200, 400 and 600 MPa for 2.5, 15 and 30 min at 8 ºC) 
in IgA, IgM and IgG concentrations, and lysozyme and lactoperoxidase activity 
in human milk and colostrum. We found that HPP treatments at 200 and 400 
MPa did not cause significant decreases in all of the Igs and lysozyme 
(p>0.05). Holder pasteurisation, on the other hand, led to significant losses of 
these antimicrobial proteins. Lactoperoxidase activity was not detected. The 
combined effect of HPP and high temperature (500, 700 and 900 MPa at 40, 60 
and 80 ºC for 15 min) in lysozyme activity of human milk was also studied. We 
observed an increase in lysozyme activity after 500, 700 and 900 MPa at 40 ºC, 
and inactivation of the enzyme at 80 ºC. Moreover, a detailed literature review 
about human milk composition, milk banks and Holder pasteurisation effects, 
and HPP technology and its effects on human milk is presented. 
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Contextualisation and Thesis Structure 
The present work is divided into four different chapters. Chapter 1 consists of a 
comprehensive literature review and state of the art in what concerns human milk composition, 
human milk banks, the currently used thermal pasteurisation method and the non-thermal high-
pressure processing (HPP) technology. Chapters 2 and 3 consist of a comparative evaluation of 
thermal pasteurisation and HPP effects on immunoglobulin content and antimicrobial enzyme 
activity in human colostrum and human milk, respectively. Each one of these last two chapters 
contains an individual introduction, material and methods, and results and discussion section. 
Moreover, the three chapters above referred have individual abstract, conclusions and references 
sections. Chapter 4 features the global conclusions of the previous chapters and an analysis of the 
future work to be done in this research area. The criterion in the basis of this division is the fact that 
the first three chapters will constitute three distinct scientific papers, to be published in 
international peer-reviewed scientific journals. 
  
CHAPTER 1. Literature Review 
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CHAPTER 1 
Human Milk: Evaluating High-Pressure Processing as a Non-Thermal Pasteurisation 
Technology 
 
Abstract 
Human milk is currently seen not only as a food, but as a dynamic biologic system. 
It provides nutrients, bioactive components and immune factors, promoting adequate 
and healthy growth of newborn infants. When mothers cannot supply their children, 
donated breast milk is the nutrition recommended by the World Health Organization 
(WHO), as it is a better alternative than infant formula. However, because of the 
manner in which donor milk is handled in human milk banks (HMB) many of the 
properties ascribed to mother’s own milk are diminished or destroyed. The major 
process responsible for these losses is Holder pasteurisation. High-pressure 
processing (HPP) is a novel non-thermal pasteurisation technology that is being 
applied in food industries worldwide primarily as an alternative to thermal treatment, 
due to its capacity of inactivating microorganisms while preserving both nutritional 
and bioactive components of foods. This review describes human milk composition 
and critically discusses HMB importance and practices, highlighting HPP as a 
potential pasteurisation technology for the human milk. HPP technology is described 
and the currently existing studies of its effects in human milk presented. 
  
CHAPTER 1. Literature Review 
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1. Introduction 
During the last decades multiple scientific data have confirmed that breastfeeding is the 
optimum nutrition for term and preterm infants, at least for the first six months and, if possible, for 
the first year of life or even more (Bertino et al., 2009). The World Health Organization (WHO) 
and The United Nations Children’s Fund (UNICEF) recommend exclusive breastfeeding for the 
first six months of life and the introduction of complementary foods at six months together with 
continued breastfeeding up to two years and beyond (World Health Organization, 2010). Human 
milk provides several benefits to the infants, including enhancement of host defences, neurological 
development and gastrointestinal function (Heiman & Schanler, 2007; Lawrence & Pane, 2007). In 
addition, it enhances antioxidant defences against hydroxyl radical aggression in preterm infants 
(Ledo et al., 2009). 
Thus, besides the role that breastfeeding plays in the normal development of the infant, it 
also protects against infectious diseases in infancy and childhood. The protective effect of breast 
milk against diarrhea, respiratory and urinary tract infections, necrotising enterocolitis (NEC), 
nosocomial sepsis, otitis media and common infections in premature infants has been documented 
(El-Mohandes et al., 1997; Lawrence & Pane, 2007; Marild et al., 2004; McGuire & Anthony, 
2003). Early prospective studies reported lower rates of infection in premature infants being fed 
fresh human milk when compared with formula milk (Narayanan et al., 1980; Narayanan et al., 
1984). In the case of NEC, a published meta-analysis revealed that infants receiving human milk 
were three times less likely to develop NEC than infants receiving formula milk (McGuire & 
Anthony, 2003). Another systematic review and meta-analysis suggests that human milk might 
reduce the risk of NEC by about 79% when compared to formula milk (Boyd et al., 2007). 
Breastfeeding has also proven to have a protective effect against obesity in children (Arenz et al., 
2004). 
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2. Human milk composition 
Human milk is currently seen not only as a food, but also as a dynamic biologic system. 
This complex fluid simultaneously provides nutrients, bioactive components and immune factors 
like immunoglobulins (Igs), lactoferrin and lysozyme (Field, 2005; Lopez Alvarez, 2007).  The 
composition of human breast milk is not homogeneous; it varies over the course of lactation and 
between lactating women. It is known that many factors, such as weeks of lactation, breastfeeding 
time, gestational age, genetic factors and dietary habits are responsible for the variations in human 
milk components between individuals (Maas et al., 1998; Wojcik et al., 2009). In a single 
individual, breast milk composition may even change over the course of the day (Shubat et al., 
1989) and significantly from day to day (Butte et al., 1988). Therefore, it becomes quite difficult to 
define a general composition of human milk. 
The lactation period is divided into three different stages: colostrum (1-5 days postpartum), 
transitional milk (6-15 days after birth) and mature milk (after 15 days) (Sala-Vila et al., 2005). 
The changes in composition are greatest and occur most rapidly during the first week after birth 
(Emmett & Rogers, 1997). Table 1 shows the basic chemical composition of human milk from 
healthy women who delivered term infants in the United Kingdom (UK; data from the UK’s 
standard food analysis tables) (Emmett & Rogers, 1997) and Inner Mongolia (China) (Shi et al., 
2011) in the three stages of lactation. The nutrient concentrations presented in Table 1 for mature 
milk are in agreement with other authors (Yamawaki et al., 2005) and The United States 
Department of Agriculture (USDA) reference values (USDA, 2009). 
Table 1. Average basic nutrient composition of human milk in the three lactation stages (g/100 mL, unless 
otherwise indicated). Adapted from Emmett and Rogers (1997); Shi et al. (2011). 
Nutrient 
Colostrum Transitional milk Mature milk 
 Emmett and 
Rogers 
(1997) 
Shi et 
al. 
(2011) 
Emmett and 
Rogers 
(1997) 
Shi et 
al. 
(2011) 
Emmett and 
Rogers 
(1997) 
Shi et 
al. 
(2011) 
Water 88.2 - 87.4 - 87.1 - 
Total solids - 11.58 - 11.37 - 11.49 
Total nitrogen 0.31 1.38 0.23 1.33 0.20 1.27 
Non-protein nitrogen - 0.05 - 0.05 - 0.07 
Protein 2.0 1.33 1.5 1.28 1.3 1.20 
Lipid 2.6 3.45 3.7 3.29 4.1 3.04 
Carbohydrate 6.6 - 6.9 - 7.2 - 
Lactose - 6.79 - 6.65 - 6.97 
Energy 
a
 56 - 67 - 69 - 
Ash - 0.17 - 0.20 - 0.21 
a
 (kcal/100 mL); “-” means no available data. 
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2.1.  Proteins 
Protein and total nitrogen contents are higher in colostral milk than in transitional and 
mature milk (see Table 1). Milk proteins are of two major types: casein and whey proteins, and, 
unlike cow’s milk, approximately two-thirds of the proteins in human milk are whey proteins. The 
most representative ones are presented in Table 2. Among them the most abundant are α-
lactalbumin, lactoferrin and secretory immunoglobulin A (sIgA) (Nagasawa et al., 1973). The 
higher protein concentration in colostrum is mainly due to the higher concentration of sIgA, but the 
concentrations of IgM and IgG are also higher in colostral milk than in transitional and mature ones 
(Table 2). The concentrations of α-lactalbumin and lactoferrin both in colostral and transitional 
milk are higher than in mature milk (Shi et al., 2011). 
Table 2. Main whey protein composition of human milk in the three lactation stages (mg/mL) (Shi et al., 
2011). 
Protein Colostrum Transitional milk Mature milk 
α-lactalbumin 1.38 1.33 1.27 
Lactoferrin 3.04 3.01 2.05 
Serum albumin 0.27 0.30 0.19 
IgA 1.48 1.07 0.33 
IgG 0.46 0.22 0.19 
IgM 0.12 0.09 0.08 
 
Some proteins in the human milk, such as α-lactalbumin, lactoferrin and casein, are 
synthesised by the mammary gland whereas others, such as serum albumin, are derived from the 
mother’s blood (Lönnerdal et al., 1976). The concentration of those secreted by the mammary 
gland decreases during the first days of lactation, while those derived from the mother’s blood 
remain fairly constant (Emmett & Rogers, 1997). Igs, lactoferrin and α-lactalbumin, as well as 
other proteins with antimicrobial activity (e.g. lysozyme and lactoperoxidase), are relatively 
resistant to proteolysis in the gastrointestinal tract and contribute to the defence of breastfed infants 
against pathogenic bacteria and viruses (Lönnerdal, 2003). In agreement with this, breastfed infants 
have shown higher levels of sIgA in saliva than bottle-fed infants (Uruakpa et al., 2002). Besides, 
lactoferrin, for example, protects against cancer development and metastasis (Rodrigues et al., 
2009). 
Non-protein nitrogen (NPN) concentration does not vary significantly during the lactation 
process (Table 1), because NPN is derived mainly from the mother’s blood (Lönnerdal et al., 
1976). Functional roles of some NPN containing compounds such as taurine and other free 
aminoacids, L-carnitine and free nucleotides are not still clear. Yet it is thought that their biological 
significance is related to the infant growth and development (Ferreira, 2003). Free amino acids are 
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present in human milk in higher number and concentration than in cows’ milk, supporting the 
previous explanation. 
2.2.  Lipids 
Fat is the main source of energy in human milk and it is distinct from that in the milk of 
other animals and generally better absorbed by the infant’s gut (Emmett & Rogers, 1997). In what 
concerns lipid content of human milk the results available in literature are contradictory. Emmett 
and Rogers (1997) observed that the total fat content of breast milk in UK women increases from 
colostrum to transitional and mature milk, while recently Shi et al. (2011) found no significant 
difference in the total fat between the milk of Inner Mongolia women in the three lactation stages 
(Table 1). This can happen due to several factors, as fat content of breast milk varies between 
feeds, depending on the extent to which the breast was emptied during the previous feed, and along 
a single feed. Lipids appear to be the most variable macronutrient inter- and intra-individuals and 
with maternal nutrition (Emmett & Rogers, 1997). Regarding the effect of maternal nutrition, it 
was demonstrated that weight gain during pregnancy was directly related to higher fat 
concentration in breast milk (Michaelsen et al., 1994). Furthermore, the pattern of fatty acids in 
maternal diet influences fatty acid composition of her milk (Emmett & Rogers, 1997). Table 3 
shows the fatty acid composition of English and Chinese women’s milk along lactation. 
Fatty acids are the main components of milk fat and, while Shi et al. (2011) found no 
significant variation of these compounds during the three lactation stages, Emmett and Rogers 
(1997) presented an increasing tendency along the lactation period, mainly for saturated and 
monounsaturated fatty acids. These differences are probably explained by the intra- and inter-
individual fat variability described above. In the case of saturated fatty acids, for example, there 
were authors who obtained results similar to those found by Shi et al. (2011) (Silva et al., 2005), 
whereas others obtained higher concentration values (Sala-Vila et al., 2005). 
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Table 3. Average fatty acid composition of human milk in the three lactation stages (%, unless otherwise 
indicated). 
Fatty acid 
Colostrum Transitional milk Mature milk 
Emmett and 
Rogers 
(1997) 
Shi et 
al. 
(2011) 
Emmett and 
Rogers 
(1997) 
Shi et 
al. 
(2011) 
Emmett and 
Rogers 
(1997) 
Shi et 
al. 
(2011) 
C10:0 - 1.17 - 1.04 - 0.98 
C12:0 - 4.55 - 4.43 - 4.15 
C14:0 - 4.82 - 4.81 - 4.60 
C16:0 - 21.95 - 22.94 - 24.38 
C18:0 - 5.63 - 6.03 - 5.97 
C20:0 - 0.12 - 0.13 - 0.13 
C22:0 - 0.12 - 0.10 - 0.14 
Total saturated 1.1
a
 38.36 1.5
a
 39.48 1.8
a
 40.35 
C14:1 - Tr. - Tr. - 0.24 
C16:1 - 3.05 - 3.29 - 3.33 
C18:1 - 30.27 - 33.16 - 30.92 
C20:1 - 0.60 - 0.76 - 0.57 
C22:1 - 0.70 - Tr. - 0.22 
Total MUFA 1.1
a
 34.62 1.5
a
 37.21 1.6
a
 34.65 
C18:2 - 18.88 - 16.51 - 16.97 
C18:3 γ - 0.37 - 0.21 - 1.08 
C18:3 α - 5.27 - 3.39 - 3.29 
C20:2 - 0.35 - 0.36 - 0.37 
Total PUFA 0.3
a
 24.87 0.5
a
 20.47 0.5
a
 21.71 
Cholesterol 31
b
 - 24
b
 - 16
b
 - 
a
 (g/100 mL); 
b
 (mg/100 mL); “-” means no available data; Tr. means trace amounts. 
Among other fatty acids, human milk provides all of the dietary essential fatty acids, such 
as linoleic acid (LA; 18:2n-6) and α-linolenic acid (ALA; 18:3n-3), as well as other longer-chain 
more-unsaturated metabolites, including arachidonic acid (20:4n-6) and docosahexaenoic acid 
(DHA; 22:6n-3) that support the growth and development of breastfed infants (Innis, 2007b). Shi et 
al. (2011) found a ratio of LA to ALA of 5.2:1 which is in the range of 5:1 to 15:1 recommended 
by ESPGHAN (European Society of Paediatric Gastroenterology, Hepatology and Nutrition) 
committee on nutrition. However, these authors did not detect arachidonic acid and DHA in the 
milk of Chinese women, which were detected by other authors in Brazilian and Spanish mothers 
(Sala-Vila et al., 2005; Silva et al., 2005). 
DHA is of great importance, because it is accumulated specifically in the membrane lipids 
of the brain and retina where it plays critical roles in the visual and neural systems, including 
protection from oxidative damage, neurogenesis, neurotransmitter metabolism, membrane protein 
functions, transmission of the visual signal and regulation of gene expression (Innis, 2007a). 
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Archidonic acid and DHA are not essential in adult diets, but preterm and very young infants 
cannot synthesise them fast enough to keep up with their nutritional needs (Emmett & Rogers, 
1997). LA and ALA cannot be formed by mammalian cells, so they are secreted in milk as a result 
of the maternal diet (Innis, 2007b). Most infant formulae do not contain the whole range of fatty 
acids present in human milk and are low in some, particularly in long chain poly-unsaturated fatty 
acids (PUFAs) (Emmett & Rogers, 1997). 
2.3.  Carbohydrates 
The concentrations of total carbohydrates and lactose do not vary significantly between 
colostral, transitional and mature milk (Table 1). Lactose is the main carbohydrate in human milk 
(≈ 7 g/100 mL) and its concentration seems to be fairly insensitive to changes in diet and 
nutritional status (Emmett & Rogers, 1997). In newborns lactose is not entirely hydrolysed in the 
intestine and the small amounts of unhydrolysed lactose that reach the colon are consumed by 
bacteria, resulting in the preferential growth of bifidobacteria and lactobacilli (Coppa et al., 2006). 
Besides lactose, oligosaccharides are also present in substantial amounts in colostrum (mean of 2.1 
g/100 mL on day 4) and mature milk (mean of 1.3 g/100 mL on day 120) (Coppa et al., 1993). 
Oligosaccharides, together with proteins, are the third major components of human milk from a 
quantitative point of view, right after lactose and lipids (Zivkovic et al., 2011). 
The prebiotic role of oligosaccharides has been thoroughly described in literature and it is 
currently undoubted that they promote a bifidobacteria-dominant microflora, contributing to the 
healthy growth of infants. Several studies outline that they resist digestion and reach the colon 
where they stimulate the development of the bifidus-predominant flora (Coppa et al., 2006). As 
only trace amounts of oligosaccharides are present in cows’ mature milk (J. A. Lane et al., 2010) 
and, consequently, in cow's milk-based infant formula, breastfed infants’ microflora shows a 
predominance of bifidobacteria and lactobacilli (90%) (Harmsen et al., 2000), while formula-fed 
infants’ intestinal flora has a significantly lower number of these bacteria (40-60%), with the 
remaining composed of Enterobacteriaceae and Bacterioides (Harmsen et al., 2000; Rubaltelli et 
al., 1998). In a lesser extent, monosaccharides, mostly glucose and fuccose, are present too 
(Emmett & Rogers, 1997). 
2.4.  Vitamins 
Vitamins, as well as minerals and trace elements, have a high level of bioavailability. 
Therefore, even at low concentrations they can be well utilised (Lönnerdal, 1985). Maternal milk 
should supply all of the vitamins’ requirements, but vitamin content may vary significantly 
according to the maternal diet and, specifically, to vitamin dietary intake. Table 4 gathers the breast 
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milk vitamins’ composition of women who gave birth in the UK and in China, two countries with 
different dietary habits. 
Table 4. Average vitamin composition of human milk in the three lactation stages (mg/100 mL, unless 
otherwise indicated). 
Vitamin 
Colostrum Transitional milk Mature milk 
 Emmett and 
Rogers 
(1997) 
Shi et 
al. 
(2011) 
Emmett and 
Rogers 
(1997) 
Shi et 
al. 
(2011) 
Emmett and 
Rogers 
(1997) 
Shi et 
al. 
(2011) 
Vitamin C 7 1.7
a
 6 2.2
a
 4 1.6
a
 
Folate  2
b
 4.7
c
 3
b
 4.6
c
 5
b
 2.4
c
 
Pantothenate 0.12 204.5
c
 0.20 186.0
c
 0.25 249.3
c
 
Biotin 
b
 Tr. - 0.2 - 0.7 - 
Niacin 0.1 180.0
c
 0.1 173.8
c
 0.2 182.7
c
 
Riboflavin 0.03 16.9
c
 0.03 17.6
c
 0.03 13.7
c
 
Thiamin Tr. 6.5
c
 0.01 5.2
c
 0.02 6.3
c
 
Vitamin B6 Tr. 5.4
c
 Tr. 4.5
c
 0.01
 
4.6
c
 
Vitamin B12 
b
 0.1 - Tr. - Tr. - 
Retinol 155
b
 24.1
d
 85
b
 31.9
d
 58
b
 20.4
d
 
Vitamin D - 159.7
e
 - 97.6
e
 0.04
b
 0.2
e
 
Vitamin E 1.30 294.4
c
 0.48 174.5
c
 0.34 234.6
c
 
Vitamin K 
c
 - 22.4 - 22.7 - 0.8 
a
 (mg/100 g); 
b
 (µg/100 mL); 
c
 (µg/100 g); 
d
 (IU/100 g); 
e
 (IU/100 g
-1
); “-” means no available data; Tr. means 
trace amounts. 
Water-soluble vitamins’ concentrations are usually more affected by maternal diet than the 
concentrations of fat-soluble vitamins (Prentice et al., 1983). Emmett and Rogers (1997) reported 
that soluble vitamins as thiamine, niacin, vitamin B6, folate, pantothenate and biotin increase in 
concentration from colostrum to mature milk, while vitamin B12 and vitamin C decrease and 
riboflavin concentration remains the same. However, even though the similarity of the results, Shi 
et al. (2011) found that water-soluble vitamins, such as thiamin, niacin, vitamin B6, folate, 
pantothenate, riboflavin and vitamin C did not vary significantly along lactation. These differences 
may be explained by variations in the maternal diet. The concentration of vitamin C throughout 
lactation was, in the most recent work, lower than the concentration presented by Emmett and 
Rogers (1997). This is probably due to some traditional Chinese dietary habits; many mothers 
exclude most fruits and vegetables from their diet during 15 to 30 days after parturition, leading to 
a great decrease of vitamin C (Shi et al., 2011). In general, the results of both works were similar to 
the USDA reference values (USDA, 2009). 
Among fat-soluble vitamins, those that are most relevant in human milk are vitamin A or 
retinol and vitamins D, K and E. Emmett and Rogers (1997) observed a decrease in the human milk 
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content of vitamins A and E over the course of lactation. On the other hand, Shi et al. (2011) found 
a major decrease of vitamins D and K from colostrum to mature human milk. Vitamin A 
concentration varies according to the mother’s diet in pregnancy and lactation, that is, according to 
the vitamin A status of the mother (Mello-Neto et al., 2009). Thus, lower retinol concentrations 
found in Chinese women may be associated with maternal food choice in that region (more eggs 
and rice) (Shi et al., 2011). Regarding vitamins D and K, human milk contains small amounts of 
these vitamins. Nevertheless, they are important in the prevention of some diseases (Ala-Houhala, 
1985; P. A. Lane & Hathaway, 1985). Although there is little evidence of a relation between the 
mother’s diet and vitamin E concentration in breast milk (Emmett & Rogers, 1997), vitamin E 
concentration in Chinese mothers was lower than reference values (Emmett & Rogers, 1997; 
USDA, 2009). 
2.5.  Minerals 
The bioavailability of most minerals in human milk is much higher than in cow’s milk or 
infant formula (Emmett & Rogers, 1997), so that they can be efficiently used by the organism as 
they are present in milk in low concentrations. Results from both studies presented in Table 5 show 
similar concentrations of calcium (Ca), phosphorous (P), chlorine (Cl; except for mature milk), 
magnesium (Mg), cooper (Cu), iron (Fe), zinc (Zn; except for colostrum) and selenium (Se). 
However, Shi et al. (2011) obtained lower concentrations of potassium (K) and sodium (Na) and 
higher concentrations of iodine (I), than those presented by Emmett and Rogers (1997). Other 
studies that measured mineral and trace element composition of breast milk (Almeida et al., 2008; 
Yamawaki et al., 2005) showed similar concentrations to those obtained in the works used to create 
Table 5 (Emmett & Rogers, 1997; Shi et al., 2011). 
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Table 5. Average mineral composition of human milk in the three lactation stages (mg/100 mL, unless 
otherwise indicated). 
Mineral 
Colostrum Transitional milk Mature milk 
 Emmett and 
Rogers 
(1997) 
Shi et 
al. 
(2011) 
Emmett and 
Rogers 
(1997) 
Shi et 
al. 
(2011) 
Emmett and 
Rogers 
(1997) 
Shi et 
al. 
(2011) 
Ca 28 28.5 25 28.0 34 33.4 
P 14 14.1 16 15 15 16.7 
Cl - 84.1 86 89.7 42 88.8 
Mg 3 3.5 3 3.6 3 3.7 
K 70 46.0 57 46.3 58 50.4 
Na 47 11.0 30 16.3 15 13.8 
Cu 0.05 61.3
a
 0.04 59.0
a
 0.04 36.7
a
 
Fe 0.07 0.05 0.07 0.05 0.07 0.05 
Zn 0.6 0.3 0.3 0.3 0.3 0.2 
I
 a
 - 22.1 - 33.1 7 27.9 
Se 
a
 - 1.4 2 1.9 1 1.5 
a
 (µg/100 mL); “-” means no available data. 
The observed differences are probably due to factors included in the intra- and inter-
individual variation, such as maternal diet or nutritional status. The effect of maternal diet in the 
mineral content of human milk is not the same for all minerals, yet depends on which mineral is 
being considered. Maternal intake of certain minerals like calcium, magnesium, cooper and zinc 
does not seem to affect the breast milk concentration (Aggett, 1994; Garg et al., 1988). On the 
other hand, there is evidence that selenium concentrations in breast milk can be affected by 
maternal diet (Funk et al., 1990). 
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3. Human milk banks 
As previously stated, it’s undoubted that breastfeeding is the ideal way to nourish both term 
and preterm infants (Dewey, 2001; Morales & Schanler, 2007). Unfortunately, sometimes mother’s 
milk is unavailable or in short supply and the infant cannot be breastfed (or at least exclusively) 
(Bertino et al., 2009). What happens then if the mother is unable to meet the needs of her baby? In 
this situation human milk banks (HMB) are essential, as they provide donor milk, which is a better 
alternative than infant formula (Leaf & Winterson, 2009). Even artificial formula manufacturers 
have already acknowledge that “Formula or cow’s milk is low in functional components and can 
never be fortified to match breast milk” (Yeung & Peters, 2001). In this sense, the enormous 
volumes of human milk discarded by mothers who produce more than their infants require may 
become an invaluable resource if donated to HMB (Hartmann et al., 2007). 
Human milk banking consists in collecting, processing and storing human milk from 
lactating women with the aim of feeding it to other women’s babies. This is not a new concept; 
wet-nursing has been carried out for centuries and since 1909, when the first milk bank appeared, 
milk banking has been practised all around the world (Leaf & Winterson, 2009). Later on in the 
1900’s the development and assertive marketing of bovine infant formulas, as well as the 
emergence of HIV and the fear of other viruses and illness, hospital budget crisis and progress in 
the neonatal intensive care changed this situation, leading to closings of many banks (Jones, 2003; 
Leaf & Winterson, 2009). Nowadays, with increasing awareness of donor human milk benefits and 
safety, the interest in HMB is resurging along with the required resources (Tully et al., 2004). 
HMB are expanding in number and capacity and are particularly focused in providing 
human milk to extremely premature (gestational age below 28 weeks), premature (28 – 33 weeks) 
or ill hospitalised infants, as they need for larger amounts of protein and energy than the healthy 
term ones to achieve appropriate growth (Sauer, 2007). Thus, whenever possible, the milk of 
mothers who give birth to extremely premature or premature infants (extremely preterm and 
preterm milk, respectively) is preferred, because of its higher contents of protein, fat, carbohydrates 
and energy (Bauer & Gerss, 2011). Nevertheless, processing and storage of donor milk, as well as 
mothers’ own milk, affect some of its nutritional and immunological properties (Wight, 2001). 
In the Perron Rotary Express Milk Bank in Australia they analysed the macronutrient 
composition of pasteurised donor human milk mainly from mothers who gave birth prematurely 
(Hartmann et al., 2007). Protein, lactose and energy concentrations were similar to those of 
unpasteurised mature human milk from healthy mothers of term infants reported by other authors 
(Emmett & Rogers, 1997; Shi et al., 2011). Fat concentration was slightly higher than that obtained 
by Shi et al. (2011) and similar to that reported by Emmett and Rogers (1997). As above referred, it 
is known that preterm milk has higher macronutrient content than term milk, hence the similar 
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macronutrient concentrations between pasteurised preterm milk and raw term milk are probably 
due to losses during human milk pasteurisation. 
Figure 1 represents the WHO hierarchy of feeding choices for low-birth-weight infants 
(Arnold, 2002), which is very similar to that for regular weight babies that only do not usually 
require preterm milk. Breastfeeding is always the number one option, but for premature or sick 
infants who cannot be breastfed donated fresh preterm milk becomes the best option and donated 
fresh term mature milk the second best. Pasteurised donated breast milk is the number four in 
WHO choices, because pasteurisation diminishes the nutritional value of human milk and partially 
destroys immunological and functional factors, as described further in section “Effects of 
pasteurisation, freezing/thawing and storage”. Preterm and ordinary formula come only as the last 
choices (numbers five and six, respectively). 
 
 
Figure 1. WHO hierarchy of infant feeding choices for low-birth-weight infants. Adapted from Arnold 
(2002). 
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3.1.  Human milk banking practices 
The number of HMB is increasing day by day. Therefore, in the absence of international or 
national regulation and recognised guidelines, several countries have developed their own 
guidelines and quality standards (Baumer, 2004; Dall'Oglio et al., 2009; Hartmann et al., 2007; 
Melo et al., 2010; Updegrove, 2005). In the UK HMB can voluntarily adopt the standards of 
practice of the UK Association of Milk Banks (www.ukamb.org), but in Canada, Mexico and the 
United States (US) the Human Milk Banking Association of North America (www.hmbana.org) 
has different standards (Modi, 2006). There are few countries, such as Brazil, where governments 
have specific legislation regulating milk banking and difficulties seem to be greatly reduced 
(Arnold, 2006). The general milk banking practices will be described and explained, taking as 
example the milk banks of the Human Milk Banking Association of North America (HMBANA), 
as some procedures differ between countries. In Figure 2 a simplified scheme of the main practices 
performed in HMB in order to collect and preserve milk is presented. 
 
Figure 2. Main practices of the process conducted in HMB. 
The whole process starts with the choice of the donors. Donors are self-selected in the first 
place and are not paid, their satisfaction comes from the fact that they are able to help other babies 
in need (Updegrove, 2005). After a potential donor manifests the interest in donating her milk the 
donor screening begins. Firstly, mothers are questioned about mother and baby’s health, maternal 
lifestyle and medical issues. They have to be healthy lactating women willing to donate their 
surplus milk and must take minimal or no medication and no herbal products (Human Milk 
Banking Association of North America). Secondly, they are informed about the process of 
pumping and storing milk and asked to do some blood tests (HIV-1, HIV-2, human T cell 
lymphotropic virus (HTLV), hepatitis B and C, and syphilis) (Hartmann et al., 2007). 
Donor 
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After the blood tests results are known the donors may be approved, denied or asked to 
answer some more questions, so that a decision can be made (Updegrove, 2005). HMBANA donor 
exclusion criteria are quite extensive and include any positive blood test among the required ones, 
risk factors for HIV, use of illegal drugs, use of nicotine products, regular alcohol intake, travelling 
to the UK for more than 3 months or Europe for more than 5 years since 1980 and travelling or 
living in Cameroon, Central Africa Republic, Chad, Congo, Equatorial Guinea, Gabon, Niger, or 
Nigeria (Human Milk Banking Association of North America). The second last criterion is 
presumably based on the risks of Creutzfeldt-Jakob disease (Modi, 2006) and is not applied in 
European countries. 
Once the donor is approved she has to express the milk, manually or through the use of a 
breast pump, collect it to disinfected polypropylene bottles, label them and freeze the milk in the 
coldest part of the freezer (Hartmann et al., 2007). Then, she has to deliver it to the milk bank or 
other existing collection sites in the area (Updegrove, 2005). In the milk bank, raw donor human 
milk is stored frozen at – 20 ºC to prevent microbial growth (Pardou et al., 1994) and lipid 
peroxidation, reduce viable cytomegalovirus (CMV) and preserve vitamin C content (Baumer, 
2004). Before being delivered to medically needy individuals or medical institutions, the milk has 
to be mandatorily pasteurised to inactivate pathogenic microorganisms, part of the commensal flora 
(Molto-Puigmarti et al., 2011) and also viruses. Currently, the most frequently used method is the 
in-pack pasteurisation, known in the field as Holder pasteurisation, which is a low-temperature 
long-time (LTLT) pasteurisation technique. It consists in placing the milk in a water bath and 
heating it at 62.5 ºC for 30 minutes (Updegrove, 2005). 
In order to be pasteurised, the milk is thawed, poured into flasks and mixed carefully to 
promote homogenisation. Then, a sample of raw milk is taken for microbiology (identification and 
counting of colonies). Human milk that tests positive for certain bacteria as Staphylococcus aureus 
or any of the bacillus species is discarded. After pasteurisation a second sample is taken for 
microbiological control. Any bacterial growth in the postpasteurised sample is unacceptable and 
leads to the discarding of that donor’s milk (Updegrove, 2005). It is well known that the 
germination of spores of bacillus species, for example Bacillus cereus, can occur during heat 
treatment (Hanson et al., 2005). Usually, another sample is collected from the donor’s milk for 
nutritional analysis, before or/and after pasteurisation, depending on which bank is being 
considered. 
In the Mother’s Milk Bank at Austin one sample is collected before pasteurisation with the 
aim of evaluating the nutritional value of human milk and another one after to recheck the 
nutritional content (Updegrove, 2005). They mix together the milk from two or three donors in 
certain volumes that allow them to ensure an adequate caloric and protein value for the milk; given 
CHAPTER 1. Literature Review 
 
 
16 
University of Aveiro – Chemistry Department 
 
that human milk composition is very variable. At the end they label the bottles, which include 
nutritional information, and pasteurise the milk. Following pasteurisation the milk is quickly cooled 
in an ice bath and frozen at – 20 ºC for dispensing (Updegrove, 2005). The whole handling process 
of human milk in the banks is performed under aseptic conditions. 
There are, however, some exceptions to these general procedures. Milk banks in the UK, 
for example, do not pool donor milk, yet they prepare it in aliquots from individual donors to 
minimise the risk of multiple donor exposure (Leaf & Winterson, 2009). In some countries like 
Norway, HMB do not pasteurise donor milk; instead they use raw donor milk to feed preterm 
infants (Grøvslien & Grønn, 2009). The donors have to be screened for HIV, hepatitis B and C, 
HTLV and CMV and the milk screened for bacteria to ensure that it is free of pathogens and has 
low bacterial counts. Also in 5 of the 27 Swedish HMB raw donor milk is used (Omarsdottir et al., 
2008). 
One of the main constraints of HMB is their financial implications and the high costs of the 
final product. Even though donors of human milk are not paid, the costs of screening, 
pasteurisation, storage and transportation are high. Do the benefits justify the costs? Some authors 
have made simple comparisons in order to assess economical potential of these banks. As recently 
reviewed by Leaf and Winterson (2009) in UK, costs of transport, pasteurisation, storage, staff 
training and administration were determined to be up to £150/litre (Tully, 2000). It is much higher 
than the cost of preterm formula (around £10/litre), but of minor significance when compared to the 
cost of a neonatal bed (around £189-£355/day in 2000) (O'Neill et al., 2000). 
Likewise, Simmer and Hartmann (2009) compared the cost of pasteurised donor human 
milk with the cost of staying in the neonatal intensive care unit (NICU). In the US, private non-
profit milk banks charged about US$3.00 per 30 mL of donor human milk in 2009, which was 
equivalent to AU$120 per litre at the time. Following Australian NICU standard, they assumed that 
a hypothetical infant being fed exclusively donor milk for 24 weeks would require 10 L of milk, 
which would cost around AU$1200. They added that this cost is equivalent to less than a day’s care 
in their NICU. Therefore, if providing donor milk helps prevent some of the complications 
attributed to artificial formula use, the length of stay in the NICU may be significantly reduced and 
the investment greatly monetised (Simmer & Hartmann, 2009). 
3.2.  Effects of pasteurisation, freezing/thawing and storage 
Due to the effects of heating, cooling, freezing, and storing, some of the most valued and 
precious components of human milk are diminished or destroyed, while feeding fresh milk (or at 
least fresh frozen and not heated) preserves most of the components (Lawrence & Lawrence, 
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2011). This section will be focused on reviewing the effects of pasteurisation, freezing and thawing 
and cold storage on human milk. 
Even though pasteurisation of donor human milk eliminates the risk of transmission of 
infectious agents, it does affect some of the nutritional and immunological components of human 
milk (Wight, 2001), as evidenced by numerous studies. A recent study, which determined the effect 
of Holder pasteurisation, freezing at – 20 ºC and thawing on fat, protein and lactose concentrations 
in human milk, found a significant reduction of fat (5.5%) and protein (3.9%) concentrations 
following these processes (Vieira et al., 2011). It was demonstrated that the major process 
responsible for these losses was pasteurisation. Lactose concentration did not suffer a significant 
reduction (0.5%) throughout the processes studied. A previous study where pooled human milk 
was subjected to Holder pasteurisation and storage at – 20 ºC up to 90 days obtained similar 
reduction of fats (of 6%) (Lepri et al., 1997). In addition, both of the works are in agreement that 
freezing and thawing may alter the structure of the fat globule, causing lipolysis of breast milk. 
Lepri et al. (1997) also reported that pasteurisation induced triglyceride hydrolysis. In this 
work, the amount of free fatty acids (FFAs) doubled after pasteurisation and rose even more after 
storage. Wardell et al. (1981) found lower percentage of linoleic (C18:2; -22%) and linolenic 
(C18:3) acids in milk after freezing, thawing and Holder pasteurisation. Another study found that 
the proportion of medium-chain saturated fats (C12:0, C14:0) was increased after pasteurisation, 
with a trend towards a decreased proportion of oleic acid (C18:1n-9) (Ewaschuk, Unger, O'Connor, 
et al., 2011). In contrast, other studies showed no significant differences in human milk fatty acid 
proportions before and after pasteurisation (Fidler et al., 1998; Henderson et al., 1998; Romeu-
Nadal et al., 2008). Nevertheless, a randomised study found that feeding preterm infants with 
pasteurised milk as compared with raw milk reduced fat absorption in 17%, causing them to gain 
less weight (Andersson et al., 2007). There is the likelihood that these last results are due to 
inactivation of milk lipases during pasteurisation, which will be discussed further on, and the 
consequential removal of the filaments from milk fat globules (Buchheim et al., 1988). Besides 
these macronutrients, it has been demonstrated that Holder pasteurisation does not affect the 
concentration and pattern of oligosaccharides in human milk (Bertino et al., 2008). 
The most severe effects of Holder pasteurisation on human milk are reported to be in 
immune factors and certain enzymes. As reviewed by Heiman and Schanler (2007), the main 
immune factors and enzymes decreased are: sIgA (20 to 50%), total IgA (0 to 50%), lactoferrin (0 
to 65%), lysozyme (0 to 65%), lymphocytes (100%), lipase (100%) and alkaline phosphatase 
(100%) (Baum, 1980; Garza et al., 1986; Hamprecht et al., 2004; Koenig et al., 2005). In addition, 
it is estimated that 34% of IgG in human milk is degraded by pasteurisation (Evans et al., 1978). 
Henderson et al. (1998) confirmed that the two lipases present in human milk, lipoprotein lipase 
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(LPL) and bile salt-stimulated lipase (BSSL), were completely inactivated during pasteurisation, 
while amylase lost about 15% of its initial activity. 
Recently, Holder pasteurisation method was shown to structurally modify and decrease 
BSSL, lactoferrin and components of the immune system and increase lysine bioavailability (Baro 
et al., 2011). It was also demonstrated that pasteurisation significantly reduces the concentrations 
of several immunoactive compounds present in the human milk, such as interferon-γ (IFN-γ), 
tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-10 and hepatocyte growth factor 
(HGF) (Ewaschuk, Unger, O'Connor, et al., 2011). These results are in accordance with a previous 
study where the authors observed that cytokine concentrations declined following pasteurisation, 
and suggested that more pro-inflammatory than anti-inflammatory cytokines are retained (Giorgi et 
al., 2006). Transforming growth factors α (TGF-α) and β2 (TGF-β2) are preserved in milk heated at 
56.5 ºC for 30 minutes (McPherson & Wagner, 2001). 
Vitamin content before and after Holder pasteurisation was investigated as well, and, while 
vitamins A, D and E were not affected, the concentrations of vitamins C, folacin and B6 were 
lowered in 36, 31 and 15%, respectively (Van Zoeren-Grobben et al., 1987). A latest study 
confirmed that vitamin E did not vary and that pasteurisation significantly decreased vitamin C 
(20%) and ascorbic acid (16%) levels. (Molto-Puigmarti et al., 2011). There were no changes in the 
mineral content of milk regarding minerals like Ca, P or Na (Williamson et al., 1978). 
Cold storage, freezing and thawing of donor human milk are similar to the practices used 
by a mother with her own milk for her baby, but these processes may affect human milk 
composition, too. Garza et al. (1986) determined the effects of freezing at – 20 ºC for 3 months in 
some components of raw human milk. They observed a small decrease in total IgA (3%), but no 
changes in sIgA or lactoferrin concentrations. Lysozyme concentration was reduced up to 20% and 
white blood cells were almost completely destroyed. In addition, they verified that storage in the 
refrigerator at 4 ºC for 24 hours results in several losses: vitamin C (40%), lysozyme (40%), 
lactoferrin (30%), lipase activity (25%), sIgA (40%), and specific sIgA antibody (0 to 60%). 
Refrigerated milk showed a reduction of 40% in its phagocytic activity, an increase in the number 
of cellular elements and also a large increase in FFAs, suggesting spoilage (Garza et al., 1986). 
Evans et al. (1978) reported no appreciable losses of lactoferrin, lysozyme, IgA and IgG after 
storage by deep freezing at – 20 ºC for 3 months. 
We can conclude that collecting, processing, and storing of human milk substantially 
diminishes its advantages and its most valued properties. Moreover, the loss of several biologically 
active milk components, mainly due to the heat treatment, is the bottleneck obstructing the 
diffusion of donor HMB worldwide. Therefore, milk banks should be committed to finding novel 
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pasteurisation technologies that can assure microbial and viral inactivation, while preserving the 
nutritional, immunological and functional value of human milk. 
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4. High-pressure processing 
Nowadays, increasingly demanding consumers require not only safe, but also high quality 
and fresh-like foods. This implies less extreme treatments and fewer or even no additives (Palou et 
al., 2007). There are several physical (e.g. heating, freezing, dehydration and packaging) and 
chemical (e.g. acidification and use of preservatives) food preservation methods, but the most 
commonly used is thermal treatment (e.g. pasteurisation and sterilisation). Even though heat 
treatment significantly reduces microbial levels and growth, it often results in undesired changes in 
foods, such as losses of colour, flavour, texture, smell and nutritional value, that is, an overall 
reduction of freshness and quality of the final product (Hogan et al., 2005). Therefore, new 
processing technologies are required to provide safe, fresher-tasting, nutritive foods with a 
reasonable shelf life and improved convenience (Ramirez et al., 2009). High-Pressure Processing 
(HPP) potentially answers many, if not all, of these challenges (Hogan et al., 2005). 
HPP is a novel non-thermal processing technology of great interest in food research and 
industry, primarily as an alternative to thermal treatment. It consists in subjecting the desired 
product to pressures that frequently range from 100 to 1000 MPa, i.e., 1000 to 10 000 times 
atmospheric pressure, and involves the following general steps: placing the product (liquid or 
solid), with or without packaging, in an adequate vessel and, following closure of the vessel, 
applying pressure either through a piston or a pump (Huppertz et al., 2006). 
The use of high pressure per se is not new; this technology has long been applied in various 
non-food industries, including production of plastics, ceramics, metal-forming and pharmaceutical 
tablet manufacture (Schaschke, 2011). Even today high pressure is still being studied for other 
innovative non-food applications (Oliveira et al., 2012; Salvador et al., 2010). HPP effects on 
foods were first studied in the late nineteenth century, when it was observed that processing milk at 
670 MPa for 10 min achieved five to six microbial logarithmic reductions, extending shelf life up 
to 4 days after processing (Hite, 1899). Even though HPP has been successfully applied in foods 
for over 100 years, the commercialisation of products processed by HPP is fairly recent (Table 6). 
This technology took about a century to reach the market mainly due to its high cost, lack of 
commercial equipment capable of operating with minimal disruptions and processing large 
amounts of food, and lack of investment in the emerging technologies by the food industry, 
particularly in Europe (Patterson et al., 2006; Torres & Velazquez, 2005). 
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Table 6. Remarkable events in the history of HPP for food products. Adapted from Patterson et al. (2006) 
and supplemented with informations from Food ingredients first (2011); Nguyen et al. (2010); Tonello 
(2011). 
Year Event(s) 
1895 Royer (France) used high pressure to kill bacteria experimentally 
1899 Hite (USA) used high pressure for food preservation 
1980s Japan started producing high pressure jams and fruit products 
1990s Fresherized Foods (formerly Avomex; USA) began to produce high pressure guacamole from 
avocados with a fresh taste and extended shelf life 
2000 Mainland Europe began producing and marketing fresh fruit juices (mainly citrus) and 
delicateness-style cooked meats. High pressure self-sucking oysters, poultry products, fruit 
juices and other products were marketed in the USA 
2001 HPP fruit pieces given approval for sale in the UK. Launch of the first HPP fruit juices in the 
UK 
2003 Espuña (Spain) launched a line of ready-to-microwave HPP meat snacks (e.g. bacon and 
cheese rolls). In 2005, the company developed the first high pressure sliced cured ham. 
2008 Fonterra (New Zeland) developed a pressurised antibody rich colostrum beverage 
2009 FDA approval of the pressure-assisted thermal processing (PATP) for production of low acid 
foods, such as mashed potatoes 
2011 Starbucks aquired Evolution Fresh with the aim of bringing premium HPP juices to the 
marketplace 
 
In the 1980s, the desire for fresh long shelf life products in Japan brought to the market the 
first HPP product, a fruit jam (Table 6), as these needs could not be fully satisfied by any other 
existing technology (Patterson et al., 2006). Since then, a number of HPP foods from fruit juices to 
fish products like raw squid appeared in the Japanese markets (Hayashi, 1992). In the USA, foods 
such as avocados, oysters and other shellfish, and meat products have greatly benefited from high 
pressure in terms of fresher taste, extended shelf life and consumer safety (HPP effectively reduced 
the number of spoilage and pathogenic microorganisms, but preserved the fresh-like 
characteristics). In Europe and the USA HPP fruit juices were and still are a commercial success, 
so that the largest coffeehouse company in the world, Starbucks, acquired Evolution Fresh in 2011 
in order to enter the Health and Wellness sector by providing premium tasteful juices (Food 
ingredients first, 2011). In just two decades HPP has clearly stood out from the set of food 
preservation emergent technologies, as reflected by the increasing number of high pressure units 
installed over the world (Figure 3), and is now a routine procedure for the processing of several 
commercialised foods. Current HPP foods on the market are mostly refrigerated or have reduced 
water activity and/or low pH to prevent bacterial spores germination, as HPP technology alone is 
limited to pasteurisation treatments (Mújica-Paz et al., 2011). 
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Figure 3. Hiperbaric data of world growth and main applications of HPP in the food industry. Courtesy of 
Hiperbaric. 
As shown in Figure 3, this technology has been used for a wide range of products: 
vegetables, meats, seafood, fish, fruits, purees and others (e.g. dairy products). In addition, HPP is 
also increasingly studied for the modifications of functional properties of foods (Correia et al., 
2011), and efforts have been made to develop new functional foods for demanding niche markets 
(Mújica-Paz et al., 2011). A prime example is the fat-free antibody rich colostrum beverage 
developed by Fonterra in New Zeland (COL+, 2009; Hembry, 2008). Because of its higher price, 
HPP products are still, yet less and less, targeted for certain niche markets with specific well-
defined needs. 
The success of new food processing technologies is highly dependent on consumers’ 
acceptance. Regarding consumers acceptance of HPP technology, there are some recent studies 
reporting that, although the knowledge of what is the “high-pressure processing” is still scarce, 
HPP has a very positive response and acceptance by the consumers when comparing with the other 
emerging processing technologies. Besides, when compared to thermally processed foods HPP 
products have a higher quality, which also contributes for its great consumer acceptance (Wright et 
al., 2007). Cardello et al. (2007) studied consumer perceptions of foods processed by diverse 
innovative and emerging technologies and concluded that irradiation and genetic modification 
resulted in the greatest negative response, meeting with consumer resistance, while high-pressure 
processing produced the most positive effect. On the other hand, Nielsen et al. (2009) studied 
consumer perception of HPP and pulsed electric field (PEF) for processing juice and baby food and 
verified that consumers perceived the naturalness, improved taste and high nutritional value of HPP 
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Figure 4. The principle of 
isostatic processing (Avure 
Technologies, 2011). 
and PEF products, but they lacked information about these technologies. When comparing the two, 
HPP showed a higher consumer acceptance. 
4.1.  Principles and operation 
It is long known that HPP (at refrigeration, ambient or moderate temperatures) inactivates 
pathogenic and spoilage microorganisms in foods with fewer changes in colour, flavour and texture 
than the conventional thermal methods (Cheftel, 1995). In this section the most important 
principles in which high pressure application effects are based, as well as the general HPP process 
will be described. 
There are two fundamental scientific principles that are applied in the high-pressure 
processing of foods. The first is based on the Le Chatelier’s Principle that states that when a system 
at equilibrium is disturbed, the system responds in order to minimise the disturbance (Pauling, 
1964). According to this, any chemical reaction, conformational change, or phase transition that is 
accompanied by a decrease in volume will be enhanced by pressure, while reactions involving an 
increase in volume will be inhibited (Cheftel, 1995). However, due to the complexity of foods and 
wide variety of phenomena that occur under pressure, it is difficult to predict HPP effects on foods 
(Palou et al., 2007).  
The second is the principle of isostatic processing or the Isostatic Rule. This principle 
states that high pressure is uniformly and nearly instantaneously transmitted throughout the food 
(Torres & Velazquez, 2008), whether there is a direct contact with the pressure medium or the food 
is hermetically sealed in a flexible package that transmits pressure (Olsson, 1995). The food is 
compressed by uniform pressure from every direction (unlike heat processing where there are 
temperature gradients) and returns to its original shape when the pressure is released (see Figure 4). 
Thus, in contrast to thermal processing, the time necessary for 
pressure processing is independent of equipment and food geometry 
and size. Therefore, a number of advantages arise from this principle: 
treatment times can be and usually are short, the surface area of the 
food does not get over-processed, scaling of laboratory and pilot plant 
findings to commercial production are both simple and safe, and 
changes in the equipment or product packaging do not require new 
pressure and time conditions and process redesign (Mújica-Paz et al., 
2011; Schaschke, 2011). None of these advantages is verified in 
thermal processes. 
Moreover, when looking at the molecular level, pressure 
does not affect the covalent bonds of various food components (e.g. 
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proteins, saccharides, vitamins, lipids and pigments), and sensory properties, nutrients or bioactive 
compounds suffer no significant losses, again in contrast to the very often highly damaging effects 
of temperature. Molecular compression is only capable of affecting the weaker bonds and forces, 
such as hydrogen bridges, electrostatic interactions and van der Walls forces. This is sufficient to 
alter the delicate molecular structures (e.g. proteins) (Schaschke, 2011) and explains the 
preservation effect of HPP. 
A high pressure system consists of a high pressure vessel and its closure, pressure-
generation system, temperature-control device, and material-handling system (Mertens, 1995). 
Industrial HPP can be a batch or semi-continuous process; solid foods or foods with large solid 
particles can only be processed in a batch mode, while liquids or slurries can be processed either 
way (Hogan et al., 2005). Currently, most high pressure machines used in the food industry are 
batch systems. Figure 5 presents three examples of modern HPP batch units. 
 
Figure 5. HPP units of three companies manufacturing industrial-scale high pressure equipments. Courtesy 
of Avure Technologies, Uhde High Pressure Technologies and Hiperbaric. 
In a batch system, after loading the vessel with the product(s) to be treated and closing it, it 
is filled with the pressure-transmitting medium, which may be plain water (as in industrial 
application on foods) or other media containing castor oil, silicone oil, sodium benzoate, ethanol or 
glycol (Hogan et al., 2005). Then air is removed from the vessel and high hydrostatic pressure is 
generated. High pressure is usually generated by direct or indirect compression, that is, either by 
reducing the volume of the pressure chamber inside the vessel using a piston for example or by 
pumping medium into the vessel, respectively (Palou et al., 2007). When the desired pressure is 
reached the pump or piston is stopped and the pressure is maintained without further energy use. At 
the end of the hold time the system is depressurised, the vessel opened and the product unloaded 
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(Hogan et al., 2005). The time spent for pressurisation, holding and depressurisation is called 
‘cycle time’. 
As noted above, the pressures commonly used range from 100 to 1000 MPa (industrial 
application in foods usually uses a maximum of 500 MPa). Physical compression during HPP 
increases the temperature of foods by approximately 2 to 3 °C per 100 MPa, because of the 
adiabatic heating (Balasubramanian & Balasubramaniam, 2003). However, it is dependent of food 
composition; foods with high fat content have higher temperature increases. Moreover, during HPP 
there is a displacement of the equilibrium associated with food pH, typically towards more acid 
values, contributing to microbial inactivation (Mathys et al., 2008). Once the pressure is release 
initial pH value is re-established. 
In batch systems the food product is generally treated in the final package to assure its 
maximum security (primarily against microbial contamination) until opening by the consumer.  As 
the volume of foods decreases with compression and expands with decompression, HPP requires 
hermetic packages that can withstand a change of volume corresponding to the compressibility of 
the product (Hugas et al., 2002), without compromising seal integrity. Food compression is about 
15% for a 600 MPa treatment, reflecting mostly the compression of its moisture content, but it 
increases if the food has empty spaces or high-fat content (Mújica-Paz et al., 2011). The 
compression of the headspace increases pressurisation time and consequently processing costs and 
it is obviously uneconomical to treat empty spaces. Thus, vacuum-packed products are ideal for 
HPP. Generally, plastic packages are also suitable, while metal cans and glassware are not (Hogan 
et al., 2005). 
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5. High-pressure processing of human milk 
HPP is the only emergent processing technology that has reached the markets of several 
countries with a variety of new products, because of its great advantages and consumer’s 
acceptance. However, regarding human milk there are only few reports on the effects of high 
pressure on its nutritional and microbial contents. Knowledge and fundamental understanding of 
pressure maintenance of macronutrients and immunological and functional agents, as well as 
inactivation of microorganisms and enzymes in human milk is still largely lacking. Thus, extensive 
investigation is required if one wants to make this a reliable alternative to the conventional Holder 
pasteurisation. To our knowledge, only four studies assessed HPP effects on human milk so far, 
those indicated in Table 7, where pressure application conditions and main results obtained are 
summarised. 
Table 7. Studies of HPP effects on diverse mature human milk components, including bacterial 
contamination. 
Reference Components HP Treatment Conclusions 
Viazis et al. (2007) Immunoglobulin A, 
lysozyme activity 
400 MPa for 30 
to 120 min at 21 
to 31 °C 
HPP samples retained significantly 
higher levels of IgA and lysozyme 
activity than Holder’s 
Viazis et al. (2008) Inactivation of five 
selected bacterial 
pathogens 
400 MPa for 0 to 
50 min at 21 to 
31 °C 
Effective in reducing the bacterial 
population; E. coli and S. aureus ATCC 
6538 are the most pressure-resistant (6-
log10 reduction after 30 min) 
Permanyer et al. 
(2010) 
Immunoglobulin A, 
bacterial load 
400, 500 or 600 
MPa for 5 min at 
12 °C 
400, 500 and 600 MPa: IgA retention of 
100, 87.9 and 69.3% (Holder: 72%); 
reduction of bacteria to undetectable 
levels 
Molto-Puigmarti et 
al. (2011) 
Vitamin C, fatty acids 
and tocopherols 
400, 500 or 600 
MPa for 5 min at 
12 °C 
Fatty acids and tocopherol did not vary 
with HPP and Holder, vitamin C was 
maintained after HPP (Holder: - 20%) 
 
 The authors of these studies also performed Holder pasteurisation in order to compare the 
results obtained by both processing technologies. The experimental conditions and results of these 
studies will be presented in more detail in the following discussion topics. It is noteworthy that all 
the four analysed mature human milk from mothers who gave birth at term, so there is not any 
published work investigating HPP effects neither on colostrum and transitional milk nor on preterm 
milk. Term milk in the early lactation stages and preterm milk are nutritionally richer than mature 
term milk, so also in this area more research is needed. 
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5.1.  HPP effects on human milk components 
Total protein, fat or carbohydrate contents after HPP have not been determined. There are 
also no studies concerning HPP effects on lactose, oligosaccharides or minerals and only one whey 
protein, one enzyme, two vitamins and thirty-eight fatty acids have been studied. As presented in 
Table 7, the human milk components that have been analysed before and after HPP are total IgA, 
lysozyme, vitamin C, tocopherols and fatty acids. 
5.1.1. Whey proteins and indigenous enzymes 
Viazis et al. (2007) were the first ones to study high-pressure processing of human milk. 
They investigated the effects of HPP on total IgA and lysozyme activity in comparison with Holder 
(or LTLT) pasteurisation. These two proteins have a remarkable antimicrobial activity and are 
significantly reduced after heating. Milk samples were processed at 400 MPa at 21 to 31 °C for 30, 
60, 90 and 120 min (HPP) or at 62.5 °C for 30 minutes (Holder). HPP samples retained 85.6, 87.1, 
80.6, and 75.4% of total IgA activity respectively, while LTLT pasteurised milk retained 51.2% 
activity. For lysozyme, pressurised human milk retained 106.9, 96.3, 96.3, and 95.8% activity 
respectively, while LTLT pasteurised milk retained 78.8% activity. These promising results 
indicated that HPP could be a better choice than Holder pasteurisation for pasteurising human milk. 
Even with treatments four times longer, HPP resulted in a higher maintenance of the both proteins; 
after 120 min of HPP lysozyme activity decreased by 4.2%, but after 30 min of LTLT 
pasteurisation its activity decreased 21.2%. For lysozyme even an increase in activity following 
treatment for 30 minutes (106.9% retention) was observed. 
Later on, Permanyer et al. (2010) studied the effect of HPP treatments on human milk IgA 
retention at equal or higher pressure levels for a shorter time. These authors pressure processed 
human milk at 400, 500 and 600 MPa for 5 min at 12 ºC and determined IgA retention following 
the treatments, comparing it with the retention after Holder pasteurisation. It was observed that 
HPP samples treated at 400, 500 and 600 MPa retained 100, 87.9, and 69.3% of IgA respectively, 
and low-temperature long-time pasteurised ones retained 72%. These findings suggest that HPP at 
400 MPa for 5 min at 12°C maintains the immunological protective activity associated with IgA 
antibodies, and even the pressure treatment at 500 MPa has higher IgA retention that the LTLT 
method. 
Both of the works give valuable information about HPP capacity to better retain proteins 
with great significance for the infant’s health (pressures ≤ 500 MPa). Currently, the only enzyme 
that has been analysed after HPP of human milk is lysozyme, but studies on the HPP of bovine 
milk reveal that most indigenous milk enzymes are quite baroresistant. As reviewed by Huppertz et 
al. (2006), most milk enzymes like plasmin, alkaline phosphatase, lactoperoxidase, xanthine 
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oxidase, phosphoisomerase, γ-glutamyltransferase and lipase are resistant to pressures up to 400 
MPa. 
High pressure effects on proteins (including enzymes) vary extensively with: the protein 
being considered; the pressure, temperature and time of the processing; and the pH, and 
composition of the food to be treated (Mújica-Paz et al., 2011). As pressure-treated proteins 
maintain their primary structure (because covalent bonds are not affected by HPP), the largest 
contribution to protein/enzyme inactivation comes from structural rearrangements of proteins under 
pressure. At pressures higher than 200 MPa changes in the tertiary structure of proteins may occur 
and are due to dissociation of hydrophobic and ionic interactions (Balny & Masson, 1993). 
5.1.2. Fatty acids 
Fat content of pressurised human milk has not been assessed yet. However, Molto-
Puigmarti et al. (2011) recently performed the analysis of thirty-eight fatty acids (from C8:0 to 
C22:6 n3) in human milk subjected to three HPP treatments and Holder pasteurisation. HPP 
treatments consisted in processing milk at 400, 500 and 600 MPa for 5 min at initial temperature of 
21 °C. No statistically significant differences in the proportions of fatty acids were detected 
between pressurised, thermally pasteurised and untreated samples. Besides, pressure did not cause 
significant isomerisation of conjugated linoleic acid (CLA) in human milk. This indicates that 
infants receiving donor human milk treated by either of the two methods would not be deprived of 
fatty acids in general. 
The authors could not guarantee that pressurisation was able to maintain the triglyceride 
structure intact, as HPP stability of human milk lipases has not been studied yet and the performed 
analysis quantified both fatty acids in lipid structures and free fatty acids (Molto-Puigmarti et al., 
2011). There is evidence that LPL in bovine milk is quite resistant to high pressures (Pandey & 
Ramaswamy, 2004; Seyderhelm et al., 1996). In accordance with the described work, no changes 
in the proportions of fatty acids and CLA were found in high pressure homogenised cow’s, ewe’s 
and goat’s milks (Rodríguez-Alcalá et al., 2009). 
5.1.3. Vitamins 
Molto-Puigmarti et al. (2011) studied HPP and Holder pasteurisation of vitamins C and E 
in human milk. The effects of pressure processing at 400, 500 and 600 MPa for 5 min (at 12 °C) 
were compared to those of thermal pasteurisation at 62.5 °C for 30 min. In terms of vitamin C, they 
determined the total vitamin C and ascorbic acid contents, and for vitamin E three tocopherol 
isomers were quantified: delta-, gamma- and alpha-tocopherols (Molto-Puigmarti et al., 2011). No 
changes in the vitamin C or the ascorbic acid contents of milk were found after HPP, while Holder 
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pasteurisation decreased them in 19.9 and 16.2%, respectively. The total vitamin C and ascorbic 
acid retentions were the same in the three HPP treatments. Regarding vitamin E, neither HPP nor 
Holder pasteurisation caused a significant decrease in the three tocopherols levels. These findings 
that HPP maintains vitamin C and tocopherol levels in human milk under the tested conditions 
agree with the idea that small molecules with no higher levels of structure, such as vitamins, are 
minimally or not affected by high pressure when samples are treated at mild temperatures (Balci & 
Wilbey, 1999). 
5.2.  HPP effects on bacteria in human milk 
There are only two studies that assess HPP effects on vegetative bacteria present in 
human milk and both of them are very recent; the first investigated the efficacy of HPP for 
inactivation of five selected pathogens (Viazis et al., 2008), while the second evaluated HPP effects 
on total bacterial population in general and bacteria of the Enterobacteriaceae family in particular 
(Permanyer et al., 2010). 
Viazis et al. (2008) chose the following pathogenic bacteria: Listeria monocytogenes 
ATCC 19115, Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923 and ATCC 
6538, and Streptococcus agalactiae ATCC 12927. They inoculated pooled donor human milk with 
each pathogen (10
8
-10
9
 CFU/mL) and subjected each one of them to a pressure treatment of 400 
MPa at 21 to 31 °C for holding times that ranged from 0 to 50 min, depending on the organism 
being treated. As in the previously mentioned studies, the results of this treatment were compared 
with those obtained after Holder pasteurisation. Holder pasteurisation resulted in a complete 
inactivation of all of the pathogens in human milk after 10 min. With respect to HPP, treatments of 
2 and 4 min resulted in a complete inactivation of L. monocytogenes and Strep. agalactiae in 
human milk, respectively. However, the other pathogens were more difficult to inactivate. After 30 
min of pressure treatment Staphylococcus aureus ATCC 25923 achieved an 8-log10 reduction and 
Staphylococcus aureus ATCC 6538 and Escherichia coli were both reduced by 6-log10. These data 
suggest that, even though Holder pasteurisation achieved higher levels of bacterial reduction in a 
shorter time for Escherichia coli and Staphylococcus aureus ATCC 25923 and ATCC 6538, HPP 
may be a viable alternative for pasteurisation of human milk. The authors highlight that it cannot be 
forgotten that HPP results in an overall improved nutritional quality of pasteurised human milk. 
More recently, Permanyer et al. (2010) studied the bacterial load of human milk after HPP 
and LTLT pasteurisation, recording total bacteria and Enterobacteriaceae counts. Raw milk 
samples presented a total bacterial count ranging from 1.3 × 10
2
 to 2.9 × 10
4
 CFU/mL and only one 
sample had a significant Enterobacteriaceae count of 3.0 × 10
1
 CFU/mL. These samples were 
subjected to three HPP treatments of 400, 500 and 600 MPa for 5 min at 12 °C. The three HPP 
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treatments reduced total bacterial and Enterobacteriaceae counts to undetectable levels, regardless 
of the initial bacterial load, as did LTLT pasteurisation. 
When comparing HPP treatment at 400 MPa in both works, although temperature is 
variable, it is possible to observe that the time necessary for vegetative bacteria inactivation is 
highly dependent of the initial contamination level (U.S. Food and Drug Administration), showing 
the importance of milk being collected and stored by the mothers in hygienic conditions and being 
handled in aseptic conditions in the HMB. Of the diverse bacterial communities in healthy human 
milk, the most abundant genera are Streptococcus, Staphylococcus, Serratia, Pseudomonas and 
Corynebacteria (Hunt et al., 2011), so more studies of HPP effects on these bacteria should be 
conducted, as they may (above certain levels) cause infections and diseases or, mainly in the case 
of Pseudomonas species, milk spoilage. However, several studies regarding HPP of bovine milk 
appear to indicate that Gram-positive species such as L. monocytogenes and S. aureus and Gram-
negative E. coli are the most baroresistant of the investigated species (Huppertz et al., 2006) and 
HPP was able to effectively inactivate these pathogens in human milk (Viazis et al., 2008). 
There is not any paper describing high pressure effects on bacterial spores, viruses, fungi or 
prions in human milk, only vegetative bacteria have been analysed. Thus, further research is 
needed to evaluate the efficacy of HPP in the inactivation of these potential hazards for the babies’ 
health, mainly relevant viral pathogens and spore-forming bacteria. 
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6. Conclusions 
Human milk has proven to provide the most appropriate nutritional, immunological and 
functional support for newborn infants. Besides the role that breastfeeding plays in the regular 
development of the infant, it also protects against infectious diseases in infancy and childhood. The 
composition of human milk is not homogeneous over the course of lactation and colostrum is 
particularly rich in proteins with immunological function. Furthermore, maternal diet is a key 
factor affecting human milk composition. 
When the mothers cannot adequately supply their children, donated fresh milk is the 
recommended nutrition by the World Health Organization (WHO), being followed by pasteurised 
donated breast milk, preterm formula and ordinary formula as the last option. Therefore, human 
milk banks (HMB) are of an extreme importance for newborns and infants that cannot be breastfed. 
Nevertheless, currently applied Holder pasteurisation is primarily responsible for a number of 
losses of bioactive compounds and immune factors, significantly decreasing the benefits of 
mother’s own milk. 
According to the published studies on the high-pressure processing (HPP) effects in human 
milk, HPP has the potential to be developed into a successful pasteurisation method for human 
milk, as it allows efficient inactivation of the studied microbial pathogens, while maintaining 
unique components that Holder pasteurisation diminishes and that are crucial for the healthy 
growth of neonates, infants and young children. There is, however, few available information 
describing HPP effects on the nutritional content of human milk. Fundamental knowledge is still 
lacking, so extensive research is required to make this a reliable alternative to the conventional 
thermal pasteurisation. 
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CHAPTER 2 
Effect of Thermal Pasteurisation and High-Pressure Processing on Immunoglobulin Content 
and Lysozyme and Lactoperoxidase Activity in Human Colostrum 
 
Abstract 
Human milk, and particularly human colostrum, is the gold standard for newborn 
nourishment. Colostrum contains the highest concentration of immune factors, being 
the most potent immune booster known to science. Human milk banks are essential 
for providing donor milk to newborns who cannot be breastfed. Holder 
pasteurisation is commonly applied to assure microbial inactivation, but degrades 
important antimicrobial components, as immunoglobulins (Igs) and lysozyme. High-
pressure processing (HPP) is able to assure microbial safety while preserving 
functional properties of foods. In this work, we investigated the effects of Holder 
pasteurisation and HPP in colostral IgA, IgM, IgG, lysozyme and lactoperoxidase. 
All of the Igs were preserved after HPP at 200 and 400 MPa, and partially lost after 
pasteurisation (20, 51 and 23% decreases for IgA, IgM and IgG, respectively). HPP 
at 600 MPa resulted in similar losses to thermal pasteurisation. Lysozyme activity 
was maintained after HPP and 44% lost after pasteurisation. Lactoperoxidase 
activity was not detected in quantifiable amounts. As far as the authors are aware, 
this is the first study evaluating HPP effects on human colostrum. 
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1. Introduction 
Breastfeeding is the recommended nutrition for newborns and infants, since human milk 
provides nutrients, bioactive components and immune factors. The unique composition of this 
complex fluid promotes adequate growth and benefits the infants in several ways; e.g. enhancement 
of host defences and prevention of many infectious diseases, as reviewed in Chapter 1. Human 
milk composition varies over the course of lactation, so that the lactation period is divided into 
three different stages: colostrum (1-5 days postpartum), transitional milk (6-15 days after birth) and 
mature milk (after 15 days) (Pons et al., 2000). Colostrum is a richer source of nutrients and 
immune factors than mature milk, being the most potent natural immune booster known to science 
(Uruakpa et al., 2002). It contains the highest concentration of proteins, mainly immunoglobulins 
(Igs) and lactoferrin, but also lysozyme and lactoperoxidase (LPO), which all have antimicrobial 
activity. These “bioactive proteins” are relatively resistant against proteolysis in the gastrointestinal 
tract and, thus, contribute to the defence of breastfed infants against pathogenic bacteria and viruses 
(Lönnerdal, 2003). 
There are several classes of immunoglobulins (IgA, IgM, IgG, IgE and IgD) and IgA, IgM 
and IgG are the major ones present in human milk (Hurley & Theil, 2011). IgA is present in human 
milk in its secretory form (sIgA) – a dimer of IgA linked together with a secretory component and a 
joining chain – and represents the predominant immunoglobulin fraction (>90%) (Goldman, 1993). 
These specific Igs function by directly binding to specific microbial antigens, blocking binding and 
adhesion, enhancing phagocytosis, modulating local immune function, and contributing to the 
infant’s immune system development (Lawrence & Pane, 2007). 
Lysozyme (EC 3.2.1.17), on the other hand, acts by degrading the outer cell wall of Gram-
positive bacteria by hydrolysing β-1,4 linkages between N-acetylmuramic acid and 2-acetylamino-
2-deoxy-D-glucose residues (Chipman & Sharon, 1969). Besides causing bacterial cell wall lysis, 
lysozyme binds endotoxin (limiting its effect), increases IgA production, and contributes to 
macrophage activation (immunomodulatory effects) (Lawrence & Pane, 2007). Lactoperoxidase 
(EC 1.11.1.7; LPO), in the presence of hydrogen peroxide (H2O2; produced in small quantities by 
cells), catalyses the oxidation of thiocyanate (part of saliva) to antimicrobial compounds, such as 
hypothiocynate or higher oxyacids, which are able to kill both Gram-positive and Gram-negative 
bacteria (Lönnerdal, 2003). 
Even though mother’s own milk is the gold standard for infant nutrition, sometimes the 
mother cannot adequately supply her child. In this case donor human milk is a better alternative 
than bovine infant formulas, because donor milk has this great array of “bioactive factors” that 
cannot be mimicked by infant formula and make human breast milk so unique (Hamosh, 2001). 
However, because of the manner in which donor milk is collected, processed and stored in human 
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milk banks (HMB) these prized properties ascribed to mother’s own milk are substantially 
diminished. The major process responsible for these losses is the low-temperature long-time 
thermal pasteurisation (LTLT), also known as Holder pasteurisation (62.5 °C for 30 min), which 
decreases IgA (up to 50%), IgG (34%) and lysozyme (up to 65%) contents, among others (Evans et 
al., 1978; Heiman & Schanler, 2007), and destroys IgM in human milk (Ford et al., 1977). 
Nevertheless, pasteurisation is a mandatory step to assure microbial safety of human milk. Hence, 
alternative pasteurisation technologies able to render better retention of human milk properties 
would be of great value. 
High-pressure processing (HPP) is a novel non-thermal or cold (under refrigeration 
temperature) pasteurisation technology that is being increasingly applied in food industries 
worldwide, primarily as an alternative to thermal treatment, due to its capacity of providing safe 
foods with similar characteristics to the raw unprocessed foods (fresher-tasting and with better 
nutritive and functional properties). A prime example of HPP potential is the pressurised antibody-
rich bovine colostrum beverage currently commercialised, that could not be accomplished by 
thermal pasteurisation (see Chapter 1). There are only few studies concerning the effect of HPP on 
mature human milk, which report 100% IgA retention after HPP at 400 MPa for 5 min at 12 ºC 
(Permanyer et al., 2010) and IgA and lysozyme activities of 85.6% and 106.9%, respectively, after 
a 400 MPa pressure treatment for 30 min at 21 ºC (Viazis et al., 2007). 
The aim of this study was to investigate and compare the effects of HPP (200, 400 and 600 
MPa for 2.5, 15 and 30 min at 8 ºC) and of a Holder-like thermal pasteurisation on total IgA, IgM 
and IgG contents, and lysozyme and lactoperoxidase activities in human colostrum. To our 
knowledge, this is the first work that evaluates HPP effects on human colostrum. 
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2. Materials and methods 
2.1.  Sample collection 
Human colostrum samples from 11 healthy mothers attending Infante D. Pedro Hospital 
(Aveiro, Portugal) were collected into sterile colostrum containers, by manual or mechanical 
expression of the breast, using an electric breast pump for the mechanical expression. All the 
material was provided by Medela (Medela, Portugal). The samples were collected 1-4 days after 
term delivery and always in the morning after the first feed of the day, comprising a total volume of 
35.2 mL. Exclusion criteria for the mothers were those followed by the Human Milk Banking 
Association of North America (HMBANA), except for the one that excludes women which have 
been in the United Kingdom for more than 3 months or in Europe for more than 5 years since 1980 
(Human Milk Banking Association of North America). The study was previously approved by the 
Ethical Committee of Infante D. Pedro Hospital and informed consent was obtained from all the 
donor mothers (see Appendix A). 
After collection, colostrum was transported to the laboratory in ice in less than 30 min, 
immediately frozen at -80 ºC and stored at -20 ºC until thermal or pressure treatments were 
performed. On the day of the treatments, the samples were thawed in a water bath, pooled to make 
a homogeneous batch and then divided into several aliquots for eleven different groups: one group 
of raw untreated colostrum, one to be thermally pasteurised, and nine for the various HPP 
treatments (200, 400 and 600 MPa for 2.5, 15 and 30 min each). Along these treatments samples 
were kept in ice slurry and at the end frozen at -80 ºC and stored at -20 ºC for subsequent analysis. 
Samples were stored at -20 ºC up to one week for lysozyme and lactoperoxidase activity 
measurement and up to one month for immunoglobulin content analysis. 
2.2.  Thermal pasteurisation 
The samples were thermally pasteurised by the Holder or LTLT pasteurisation method, 
according to the general HMBANA procedure (Updegrove, 2005). Nine polypropylene tubes 
containing aliquots of 400 µL each were placed into a water bath at 62.5 ºC with one of them 
containing bovine milk and a thermocouple (instead of human colostrum) to estimate the time that 
colostrum would take to reach 62.5 ºC. Bovine milk was used instead of human colostrum to avoid 
spending colostrum, which is collected in very small amounts. Once that temperature was reached, 
the samples were held in the water bath for 30 min. Following pasteurisation, the tubes were 
quickly cooled in an ice slurry. 
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2.3.  HPP treatments 
The pressure treatments were carried out using a hydrostatic press from Unipress 
Equipment, Model U33 (Warsaw, Poland), with a pressure vessel of 100 mL (35 mm diameter and 
100 mm height), surrounded by an external jacket, connected to a thermostatic bath to control the 
temperature. The unit has a maximum working pressure of 700 MPa and a working temperature 
between -20 ºC and 100 ºC. The pressure-transmitting fluid was a mixture of propylene glycol and 
water (60:40). 
Nine distinct treatments were performed by combining three pressure levels with three 
treatment times: 200 MPa for 2.5, 15 and 30 min; 400 MPa for 2.5, 15 and 30 min; and 600 MPa 
for 2.5, 15 and 30 min. The initial temperature of the pressure vessel was set to 8 ºC. Time to reach 
the pressure was of 0.75, 1.12 and 1.23 min, respectively, for 200, 400 and 600 MPa, resulting in 
compression rates of, respectively, 264, 360 and 426 MPa/min. For each pressure treatment, 
colostrum was previously aliquoted to eight polypropylene tubes (400 µL each), which were then 
inserted into a small flexible plastic bag that was vacuum-sealed, placed inside another plastic bag 
and sealed again, with caution not to leave air inside the two bags. 
2.4.  Immunoglobulin content analysis 
Immunoglobulins A, M and G were measured in human colostrum using Human IgA, IgM 
and IgG ELISA kits (KOMA BIOTECH), respectively, according to the manufacturer’s 
instructions. ELISA (or enzyme-linked immunosorbent assay) is an immunoassay technique 
involving the reaction of antigen and antibody in vitro, and these kits are based on the sandwich 
ELISA type, elucidated in Figure 6. In order to describe the general procedures of the kits, the letter 
X will be used as a generic designation for any of the three Igs. The kits contained all of the 
required reagents and material for IgX quantitation: a pre-coated 96 well ELISA microplate (with 
antigen-affinity purified goat anti-human IgX), plate sealers, detection antibody (horseradish 
peroxidase conjugated antigen-affinity purified goat anti-human IgX), standard protein (human 
reference serum), assay diluent (1% bovine serum albumin), color development reagents 
(tetramethylbenzidine and H2O2 solutions), stop solution (2 M H2SO4), and washing solution 
(phosphate buffered saline powder with 0.05 % Tween-20, pH 7.4). 
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Figure 6. General steps of the sandwich ELISA assay. 
In this assay, 100 µL of blank, standard or colostrum samples were added to each well of 
the pre-coated microplate in duplicate and incubated at room temperature for 1 h. The standards 
were diluted following the manufacturer’s recommended dilutions and samples were diluted from 
1:5000 to 1:10000, depending on the immunoglobulin. Then 100 µL of the diluted detection 
antibody (1:20000 to 1:50000) were added per well and incubated during 1 h at room temperature. 
Before, between and after the above steps the wells were aspirated to remove the liquid and washed 
five times with the washing solution to remove unbound molecules. Prior incubation the plates 
were covered with the plate sealers. For the color development reaction, 100 µL of color 
development solution were added to the wells and incubated for about 10 min for a proper color 
development. The reaction was stopped by adding 100 µL of the stop solution and the absorbance 
read at 450 nm in less than 20 min using a Multiskan GO microplate reader (Thermo). Total 
immunoglobulin concentrations were determined using the standard curves constructed with the 
diluted standards (Appendix B). 
2.5.  Lysozyme activity analysis 
Lysozyme activity was determined using a Micrococcus lysodeikticus based turbidimetric 
procedure recommended by Sigma Chemical Co. (Sigma, St. Louis, MO), with minor 
modifications. The principle of this assay is the lytic activity of lysozyme towards Micrococcus 
lysodeikticus cell walls (antibacterial activity). A 0.015% (w/v) Micrococcus lysodeikticus cell 
suspension (substrate) was prepared by suspending Micrococcus lysodeikticus ATCC 4698 
lyophilised cells in sodium phosphate buffer (66 mM, pH 6.24). To assure the freshness of this 
suspension, its absorbance at 450 nm (A450nm) was measured at the beginning of the analyses and 
was consistently between 0.6 and 0.7, as it should. Prior to the enzymatic reaction, the substrate 
was heated at 30 ºC in a water bath. The reaction was initiated by adding 0.10 mL of appropriately 
diluted human colostrum to 2.50 mL of substrate and, after mixing by inversion, the decrease in 
A450nm was immediately recorded for 3 min at 10 s intervals using a PerkinElmer Lambda 35 UV-
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Vis spectrophotometer (PerkinElmer Instruments). Measurements were carried out against the 
reagent blank, containing the substrate and 0.10 mL of buffer, and each sample was measured in 
triplicate. The ΔA450nm/min was obtained using the initial linear rate. One unit of lysozyme activity 
was defined as the amount of the enzyme that produces a ΔA450nm/min of 0.001 per min at pH 6.24 
at 30 ºC using a suspension of Micrococcus lysodeikticus as substrate, in a 2.6 mL reaction mixture. 
2.6.  Lactoperoxidase activity analysis 
LPO activity was determined according to the modified method of Pruitt and Kamau 
(1994). This method is based on the LPO catalysis of reactions in which H2O2 is reduced and a 
suitable electron donor is subsequently oxidised, such as reaction (1). 2,2’-azino-di-3-
ethylbenzthiazoline-6-sulphonic acid (ABTS) was chosen, since it is accepted as the electron donor 
of choice for peroxidase assay. In its oxidised form ABTS absorbs light and can therefore be 
determined by a spectrophotometric assay. 
ABTSreduced + H2O2 → 2 ABTSoxidised + 2 H2O       (1) 
In this procedure, the substrates (ABTS and H2O2 solutions) were heated at 30 ºC in water 
bath and then 1 mL of 0.3 mM H2O2 was mixed with 2 mL of ABTS in phosphate buffer (0.1 mM, 
pH 6.7) in a cuvette. Reaction was initiated by adding 0.1 mL of human colostrum (diluted and 
undiluted) to the mixture and, after mixing by inversion, monitored for 12 h with the absorbance 
recorded at 412 nm (A412nm). Measurements were carried out against the blank and each sample was 
measured in triplicate. One unit is defined as the amount of enzyme which oxidises 1 µmol 
ABTS/min at pH 6.7 at 30 ºC. 
2.7.  Statistical analysis 
Differences between treatments were tested at a 0.05 level of significance. The effects of 
pressure level and holding time were tested in a one-way analysis of variance (ANOVA), followed 
by a multiple comparisons test (Tukey’s HSD) to find which treatments were significantly different 
from one another. All data are expressed as the mean ± standard deviation. The standard deviation 
was always ≤ 10%. 
2.8.  Kinetic data analysis 
Denaturation kinetics of colostral Igs toward HPP was subjected to reaction kinetic 
analysis. Denauration of IgA, IgM and IgG at 400 and 600 MPa could be described by a first order 
model (2). According to Eq. (2), loss of Ig concentration rate (-dA/dt) is proportional to the 
denaturation rate constant (k) and the Ig concentration at each treatment time (A). 
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             (2) 
The reaction rate constant was determined from a semilogarithmic plot (3) of the Ig 
retention (A/A0) as a function of the exposure time (t). A represents the response value after HPP 
treatment and A0 is the initial value. D-values (decimal reduction time) were also calculated 
according to (4). 
    
 
  
              (3) 
    
      
 
         (4) 
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3. Results and discussion 
3.1.  Immnunoglobulins, lysozyme and lactoperoxidase in raw colostrum 
Human colostrum contains a range of antimicrobial factors, including immunoglobulins, 
the antibacterial and lytic enzyme lysozyme and the antibacterial enzyme lactoperoxidase. The 
concentrations obtained for these factors in this work are reported in Table 8. The profile of 
immunoglobulins in human colostrum is similar to that found in mature milk, with IgA level high 
in both, particularly in colostrum. IgM is the second major class in human colostrum and, as well as 
IgA, is present in its secretory form (sIgM). Human colostrum has a low content of IgG, and the 
IgG required to provide systemic immunity is transferred across placenta before birth (Hurley & 
Theil, 2011). Lysozyme is also present in high amounts in human colostrum, but rather than slowly 
declining as lactation proceeds, lysozyme activity increases progressively (Goldman et al., 1982; 
Prentice et al., 1984). Human milk contains nearly 3000-fold lysozyme activity than bovine milk. 
Lactoperoxidase activity, on the other hand, is 100-fold higher in bovine milk than in human milk 
(Shahani et al., 1980). 
Table 8. Total IgA, IgM and IgG concentrations, and lysozyme and lactoperoxidase activity in raw colostrum 
samples. 
Protein Raw colostrum samples ± SD 
Immunoglobulin A (mg/mL) 1.728 ± 0.034 
Immunoglobulin M (mg/mL) 0.200 ± 0.011 
Immunoglobulin G (mg/mL) 0.199 ± 0.010 
Lysozyme (U/mL) 18033 ± 570 
Lactoperoxidase (U/mL) Not detected 
 
In this work, IgA levels obtained for the untreated raw colostrum (Table 8) are in 
agreement with those of other authors (Shi et al., 2011). Ronayne de Ferrer et al. (1984) found a 
slightly higher IgA concentration of 2.128 mg/mL in human milk 1-10 days postpartum (colostrum 
and transitional milk), but even higher IgA concentrations in colostrum (≈ 8-9 mg/mL) were found 
by other authors (Ramírez-Santana et al., 2012; Yuen et al., 2012). IgM concentration was slightly 
higher than that found in another study (0.12 mg/mL) (Shi et al., 2011), and lower than that 
reported by Mickleson and Moriarty (1982) (mean of 0.58 mg/mL on day 3). IgG content is in 
agreement with that reported by other authors (mean of 0.19 mg/mL on day 3) (Mickleson & 
Moriarty, 1982). However, Shi et al. (2011) obtained a higher IgG concentration of 0.46 mg/mL. 
Lysozyme and lactoperoxidase are two of the most studied enzymes in human milk, due to 
their antibacterial activity. Untreated colostrum samples had a mean lysozyme activity of 18033 
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U/mL, which, assuming the average protein content of mature human milk (≈ 8-10 g/L) 
(Lönnerdal, 2003; Zivkovic et al., 2011), is very similar to that reported for mature milk (Viazis et 
al., 2007). This assumption has to be made, since the authors reported the results per g of protein. 
Regarding lactoperoxidase, no activity was detected in raw colostrum in quantifiable levels. This is 
in accordance with a previous study (Ford et al., 1977). 
3.2.  Effects of thermal pasteurisation and HPP on immunoglobulins 
Several studies have already investigated the effect of thermal pasteurisation on human 
milk, but there are only a few investigating HPP effects on mature human milk, and this is the first 
one to assess high pressure effects on human colostrum, as the authors are aware. Currently, the 
Holder pasteurisation technique (62.5 ºC for 30 min) is the most commonly employed 
pasteurisation procedure in human milk banks of several hospitals. Thus, we performed a Holder-
like pasteurisation in order to compare its effects with those of HPP on the selected bioactive 
components. Figure 7 presents the percentage of IgA, IgM and IgG retention in human colostrum 
after Holder pasteurisation and the various pressure treatments (200, 400 and 600 MPa for 2.5, 15 
and 30 min at 8 ºC). IgA, IgM and IgG concentrations (mg/mL) before and after all of the 
treatments can be seen in Appendix C. 
It is noteworthy that, due to the limited amount of sample and the variety of treatments to 
be performed, small aliquots (400 µL) were thermally pasteurised. As heat is transferred from the 
outside (water bath) to the inside of colostrum samples, forming a temperature gradient, an increase 
in the volume of colostrum to be treated would require more time to reach the temperature of 62.5 
ºC in the “cold point”, thus leading to more over-heated areas on the surface. As larger amounts of 
human milk are pasteurised in human milk banks, a greater destruction of its bioactive properties 
would be expected after Holder pasteurisation. High pressure is uniformly and nearly 
instantaneously transmitted throughout the food (Torres & Velazquez, 2008), so that its effects are 
independent of the volume of colostrum to be processed. 
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Figure 7. Percentage of IgA, IgM and IgG concentration in human colostrum before and after Holder 
pasteurisation and the HPP treatments studied. Data are presented as a percentage considering 100% the 
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value obtained for colostrum before any treatment (raw or unprocessed colostrum). Bars with the same letter 
are not statistically different (p<0.05). 
3.2.1. IgA 
Total IgA and sIgA are among the most studied human milk constituents (mainly in mature 
human milk), and diverse authors reported variable losses of this immune factor after Holder 
pasteurisation. Ford et al. (1977) found an IgA reduction of 20%, and, more recently, Permanyer et 
al. (2010) obtained a similar decrease (of 28%) in the IgA content. Also Czank et al. (2009) 
reached a sIgA decrease of 28% after LTLT pasteurisation of human milk. Accordingly, in the 
present study the LTLT Holder pasteurisation caused a significant decrease of 20% in human 
colostral total IgA (p<0.05; 80% retention). There are, however, studies that present higher IgA 
losses of 62% in colostrum (Koenig et al., 2005) and of 64% mature human milk (Braga & 
Palhares, 2007; Viazis et al., 2007), whereas other authors report no losses (Evans et al., 1978). 
Regarding the pressure treatments performed, our data show that IgA content is retained 
after HPP at 200 and 400 MPa for 2.5, 15 and 30 min, and 600 MPa for 2.5 min at 8 ºC (Figure 7, 
A). Increasing the hold time at 600 MPa for 15 and 30 min resulted in significant IgA losses of 20 
and 26%, respectively, which are similar to those caused by Holder pasteurisation. These results 
are in agreement with those obtained by Permanyer et al. (2010) for mature human milk, as 100% 
IgA was maintained after HPP at 400 MPa and significant losses were verified after 600 MPa for a 
time higher than 2.5 min (5 min) at 12 ºC. Viazis et al. (2007), on the other hand, found significant 
reductions of 17 and 14% in IgA content and activity, respectively, after 400 MPa for 30 min at 21 
ºC (estimated final temperature of 31 ºC). Therefore, it is arguable that the higher temperature at 
which human milk samples are pressure-processed can play a role in IgA partial inactivation. 
Either way, in all of the studies HPP at 400 MPa for various holding times proved to be more 
efficient than Holder pasteurisation in preserving the IgA content of human milk. 
3.2.2. IgM and IgG 
Although the effect of Holder pasteurisation on human milk IgM and IgG has not been as 
thoroughly studied as its effect on IgA, there is evidence that these Igs are not stable to such heat 
treatment (Ewaschuk, Unger, Harvey, et al., 2011). IgM was found to be destroyed in human 
colostrum (Koenig et al., 2005) and mature milk (Ford et al., 1977) after Holder pasteurisation. In 
the last two studies IgM initial content was very low (0.014 and 0.10 mg/mL, respectively). In this 
work, IgM content of human colostrum was significantly reduced by 51% after thermal treatment 
(p<0.05). IgM content of unprocessed colostrum in the present work is twice as much as that 
reported by Ford et al. (1977) for raw human milk, and they heated higher quantities of milk (1.5 
mL) than colostrum in the present work (400 µL), leading to more time to reach the desired 
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pasteurisation temperature (62.5 ºC). Therefore, it is likely that these two factors resulted in more 
IgM destruction. 
Actually, there is still no literature concerning HPP effects on IgM or IgG contents in 
human milk. The present study shows no significant reduction of IgM in colostrum for a wide 
range of pressures and holding times (200 and 400 MPa for all studied holding times; p>0.05). At 
600 MPa for 2.5 min IgM content is significantly reduced in 21%. The pressure treatments at 600 
MPa for 15 and 30 min caused a significant destruction of IgM (59 and 60%, respectively), similar 
to that caused by the Holder-like pasteurisation (Figure 7). 
The reports of IgG reduction caused by Holder pasteurisation in the literature are not 
consistent. While Evans et al. (1978) obtained 34% reduction of IgG content after pasteurisation of 
mature milk,  Koenig et al. (2005) found more than twice as much IgG destruction (≈ 72%) in 
colostrum. Our results show a significant 23% colostral IgG reduction after Holder pasteurisation 
(p<0.05). In relation to the pressure treatments, HPP at 200 and 400 MPa preserves IgG content, as 
no significant differences were found after these HPP treatments (p>0.05; Figure 7). HPP at 600 
MPa for 2.5 min resulted in a significant 21% decrease in IgG content (identical to the 23% loss 
after pasteurisation). The pressure treatments at 600 MPa for 15 and 30 min achieved the highest 
IgG reductions of 35 and 40%, respectively. These results confirm that HPP between 200 and 400 
MPa up to 30 min maintains not only the IgA content in human milk (colostrum and mature milk), 
but also IgM and IgG concentrations in human colostrum. 
3.3.  Effects of thermal pasteurisation and HPP on lysozyme 
Lysozyme is known to be highly heat stable at acidic pH, but heat labile at neutral pH. As 
human milk pH is around 7-7.4 (Morriss et al., 1986), this enzyme is thus heat labile in human milk 
(Ford et al., 1977). Significant losses in lysozyme content after Holder pasteurisation have been 
reported for human colostrum (≈ 74%) (Koenig et al., 2005) and human milk (from 24 to 61%) 
(Czank et al., 2009; Evans et al., 1978). Moreover, Viazis et al. (2007) reported a 21% loss of 
lysozyme activity in mature human milk after Holder pasteurisation. The percentage of lysozyme 
activity retention found in this work for human colostrum after Holder pasteurisation and the 
various pressure treatments (200, 400 and 600 MPa for 2.5, 15 and 30 min at 8 ºC) is presented in 
Figure 8 (see Appendix C for lysozyme activity values (U/mL)). In accordance with the reported 
results, data of the present study show a significant decrease in lysozyme activity of 44% after 
pasteurisation of human colostrum (p<0.05). This decrease is, however, greater than that reported 
by Viazis et al. (2007). 
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Figure 8. Percentage of lysozyme activity in human colostrum before and after Holder pasteurisation and the 
HPP treatments studied. Data are presented as a percentage considering 100% the value obtained for raw 
colostrum. Bars with the same letter are not statistically different (p<0.05). 
All the pressure treatments studied did not cause significant differences in lysozyme 
activity (p>0.05) comparing to the raw unprocessed colostrum samples (Figure 8). Lysozyme 
activity was maintained after all of the HPP treatments, even at higher pressures and holding times. 
These results are in agreement with those presented by Viazis et al. (2007) for human mature milk. 
This pattern of enzyme activity retention after HPP has also been demonstrated for various 
enzymes in bovine milk. As reviewed by Huppertz et al. (2006), most milk enzymes are quite 
baroresistant, with plasmin, alkaline phosphatase, lactoperoxidase, xantine oxidase, 
phosphohexoseisomerase, γ-glutamyltransferase or lipase being resistant to pressures as high as 
400 MPa. Besides, unlike thermal denaturation, pressure induced denaturation from pressures of 
100 to 400 MPa may be reversible, probably because covalent bonds remain unaffected, making 
the effect of pressure only temporary (Hayakawa et al., 1996). 
3.4.  Effects of thermal pasteurisation and HPP on lactoperoxidase 
LPO activity was not detected in quantifiable levels neither in raw nor in any of the treated 
colostrum samples, even when longer reaction times were studied (up to 12 h) and higher amounts 
of colostrum were used. To confirm that the assay was working properly, tests were made using 
diluted bovine milk instead of human colostrum and 1 min was enough to record LPO activity, as 
reported by other authors (Fonteh et al., 2002). As above referred, this is in accordance with a 
previous study (Ford et al., 1977). Nevertheless, other authors were able to detect LPO activity in 
colostrum and mature milk using different substrates in the enzymatic assay (Gothefors & 
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Marklund, 1975; Shin et al., 2000). Thus, to choose other assays with a lower detection limit may 
be an appropriate approach to quantify LPO activity in the future. 
3.5.  HPP denaturation kinetics of human colostrum immunoglobulins 
As slight decreases in Igs concentration were detected after HPP of human colostrum at 
400 MPa and significant losses were found after 600 MPa with increasing treatment times (0, 2.5, 
15 and 30 min), these data were subjected to reaction kinetic analysis and could be described by a 
first order kinetic model (see Appendix D). The degree of Igs denaturation increased with pressure 
and treatment time. Data of Igs concentration at 200 MPa could not be adjusted to this model, as no 
linear decrease of Igs retention (A/A0) with increasing treatment times was observed (Appendix D). 
The denaturation kinetic parameters k (reaction rate constant) and D (decimal reduction time) were 
calculated for HPP at 400 and 600 MPa and are presented in Table 9. It should be noted that, due to 
the limited treatment times studied, this is just a preliminary determination of these parameters. To 
obtain accurate k and D-values more treatment times have to be studied for each of these pressure 
levels. In any case, these preliminary data enable the attainment of some conclusions. 
Table 9. Kinetic parameters for HPP denaturation of IgA, IgM and IgG in human colostrum, assuming a first 
order reaction. 
Immunoglobulin Pressure (MPa) k-value (min
-1
) r
2
 D-value (min) 
IgA 
400 1.22  10-3 0.917 1919 
600 1.46  10-2 0.999 158 
IgM 
400 5.13  10-3 0.999 452 
600 5.75  10-2 0.989 40 
IgG 
400 4.66  10-4 0.821 4941 
600 9.78  10-3 0.905 235 
 
Linear regression analysis showed high coefficients of correlation (except for IgG at 400 
MPa), among those reported in literature for this type of analysis (Ludikhuyze et al., 2001; Tayefi-
Nasrabadi et al., 2011). D-values for 400 MPa were almost 10-fold higher for IgA and IgM at 400 
MPa than at 600 MPa, which means that treatments at 400 MPa require almost 10 more time to 
reduce these Igs concentration in one logarithmic cycle than treatments at 600 MPa, that is, to 
reduce its concentration in 90%. For IgG this difference is even more extended; D-value at 400 is 
about 20-fold higher than 600 MPa. When comparing the different Igs, it can be concluded that 
IgM is the most pressure labile (lowest D-values) and IgG the most pressure stable (highest D-
values). This tendency of pressure stability is in agreement with literature regarding thermal 
stability of the same Igs (Ewaschuk et al., 2011). Both pressure and thermal stability of IgA and 
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IgG are quite similar and those of IgM are much lower. Still, a study of thermal denaturation of 
buffalo milk Igs reported IgA as being the most thermal labile Ig, followed by IgM (El-Loly et al., 
2007). 
To our knowledge, there are no reported data of high pressure denaturation of Igs in human 
colostrum or milk. For bovine milk IgG, the reported D-value at 600 MPa is lower than that 
obtained for human colostrum, about 71 min (Mazri et al., 2012). As referred above, these are only 
preliminary results. The overall results of IgA, IgM and IgG seem to indicate that pressure 
denaturation at 600 MPa may follow a biphasic denaturation pattern, faster in the first 15 minutes 
and slower in the minutes after. These results give valuable preliminary information and should be 
considered in the design of pressure treatments of human colostrum to preserve its Igs structure and 
thus biological function. 
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4. Conclusions 
In the present work, it was found that HPP of human colostrum at pressures of 200 and 400 
MPa for 2.5, 15 and 30 min did not significantly decrease IgA, IgM and IgG contents. For IgA, 
HPP at 600 MPa for 2.5 min did not cause significant differences as well, when comparing to raw 
colostrum concentrations. In contrast, Holder pasteurisation significantly reduced IgA, IgM and 
IgG initial concentration in 20, 51 and 23%, respectively. Pressure processing at 600 MPa for 15 
and 30 min also caused significant reductions in all of the Igs, similar or even greater than those 
caused by Holder pasteurisation. It was verified that IgM is the most pressure labile Ig (lower D-
value) and IgG the most pressure stable (higher D-value). Regarding lysozyme activity in human 
colostrum, the wide range of pressure treatments conducted was able to maintain this antimicrobial 
enzyme activity. Holder pasteurisation, on the other hand, caused a significant decrease of 44% in 
its activity. 
We may conclude that HPP at 200 and 400 MPa (for all of the holding times tested) 
permits a much better retention of IgA, IgM, IgG and lysozyme in human colostrum than Holder 
pasteurisation, but HPP at 600 MPa for 15 and 30 min does not. Therefore, HPP is a potential 
alternative for the pasteurisation of this valuable food for newborns. Nevertheless, further research 
is required to determine HPP capacity of retaining other nutritional and functional components of 
human colostrum in particular, and human milk in general. 
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CHAPTER 3 
Effect of Thermal Pasteurisation and High-Pressure Processing on Immunoglobulin Content 
and Antimicrobial Enzyme Activity in Human Milk 
 
Abstract 
Immunoglobulins (Igs) A, M and G, lysozyme and lactoperoxidase in human milk 
play an important role in the prevention of infectious diseases, and are not present in 
bovine-based infant formulas. They are, however, strongly decreased after Holder 
pasteurisation in human milk banks. The aim of this work was to assess high-
pressure processing (HPP) as a potential alternative to Holder pasteurisation. Mature 
human milk was subjected to various HPP treatments and Holder pasteurisation, and 
examined for its content of Igs, lysozyme and lactoperoxidase. HPP at 200 and 400 
MPa at 8 ºC proved to retain much higher contents of IgA, IgM and IgG than 
pasteurisation, which decreased them in 27, 69 and 26%, respectively. Pressure 
treatments at 600 MPa for 2.5 min were also more effective than pasteurisation in 
retaining these biochemical components, but 600 MPa for 15 and 30 min is no 
longer a better alternative. Lysozyme activity was maintained or even increased after 
all of the HPP treatments at 8 ºC, and 50% inactivated by Holder pasteurisation. 
Furthermore, HPP at higher temperatures (40 ºC) significantly increased lysozyme 
activity in 43, 50 and 16% for 500, 700 and 900 MPa, respectively, during 15 min. 
The milk contained no detectable lactoperoxidase activity. 
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1. Introduction 
The World Health Organization (WHO), the European Society for Paediatric 
Gastroenterology, Hepatology, and Nutrition (ESPGHAN), and many professional associations and 
health care workers recommend exclusive breastfeeding for the first 6 months of life and 
continuation of breastfeeding after the introduction of complementary foods up to two years and 
beyond, as long as mutually desired by mother and child (Agostoni et al., 2009; World Health 
Organization, 2010). Moreover, these organizations strongly advise and encourage legal 
regulations that facilitate breastfeeding, such as allowance of maternity leave for at least 6 months 
and protection of working mothers. There are several indicators of breast milk benefits in infancy 
and even later in the child’s life; from reducing the risk of infectious diseases like necrotising 
enterocolitis (NEC), diarrhoea, respiratory tract infections and acute otitis media (Boyd et al., 
2007; Quigley et al., 2007; Sabirov et al., 2009) to helping prevent obesity (Arenz et al., 2004) and 
death. It has been reported that about 1.45 million children’s lives are lost per year due to 
suboptimal breastfeeding in developing countries (Lauer et al., 2006). 
There are numerous immunomodulatory components in breast milk, which are responsible 
for its effects in preventing or reducing the above referred complications. For instance, 
immunoglobulin (Ig) transfer through milk is key in providing passive local immunity to the 
newborn, mostly IgA and, in a lesser extent, IgM and IgG (Hurley & Theil, 2011). Besides, there 
are two major enzymes with antimicrobial activity in human milk that also may impact the infant’s 
immune system: lysozyme and lactoperoxidase. These components are particularly invaluable to 
sick, low-birth-weight and extremely low-birth-weight infants who are born with a very naive 
immune system and are often hospitalised for an extended period in a neonatal intensive care unit 
(NICU). When mother’s breast milk is unavailable, donor human milk is preferred to cow’s milk-
based infant formula, as it is not only much closer to mother’s own milk in its overall nutritional 
composition (e.g. lower energy and protein contents), but also avoids exposure of the infant’s gut to 
xenogeneic proteins and provides all of its natural nutritive and non-nutritive bioactive components 
that infant formulas cannot supply (Akinbi et al., 2010; Hamosh, 1997). 
Donor milk is commonly pasteurised in human milk banks (HMB) to avoid potential 
transmission of infectious agents, typically by heating to 62.5 ºC for 30 min (Holder pasteurisation) 
(Updegrove, 2005), a procedure that greatly decreases bioactive and immunoactive components of 
human milk. This subject has been recently reviewed, and IgA, IgM, IgG and lysozyme levels can 
be reduced up to 48, 100, 34 and 60%, respectively (Ewaschuk et al., 2011). These losses of 
immune factors through pasteurisation may have significant clinical implications to infants at high 
risk of developing infectious diseases, such as NEC. Therefore, alternative pasteurisation 
technologies able to preserve immune components while inactivating potential pathogens should be 
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undoubtedly explored. High-pressure processing (HPP) technology has already proven to be able to 
answer this challenge for various foods. 
HPP effects on foods were first studied more than a century ago, when it was observed that 
processing milk at 670 MPa for 10 min resulted in five to six microbial logarithmic reductions 
(Hite, 1899). Furthermore, high pressures are uniformly and nearly instantaneously transmitted 
throughout the foods, and they do not affect covalent bonds, only weaker bonds and forces (e.g. 
hydrogen bridges, electrostatic interactions and van der Walls forces). These features ascribe HPP 
many advantages over thermal and other non-thermal processes, namely short processing times, 
minimal heat exposure, no over-processed areas, and retention of sensory properties, nutrients and 
bioactive compounds (Schaschke, 2011). Even though this technology took a long time to reach the 
market (in 1980s), in just two decades HPP has clearly stood out from the other emergent 
preservation technologies, owing to its capacity of fully satisfying the need for fresh, nutritive, long 
shelf life products (Patterson et al., 2006). However, HPP technology alone is limited to 
pasteurisation treatments. Sterilization of foods is only possible by combining high pressures with 
high temperatures in pressure-assisted thermal sterilization (PATS) (Mújica-Paz et al., 2011). 
Pressure treatments at temperatures higher than 50 ºC are reported to be effective for some bacterial 
spores (Paredes-Sabja et al., 2007). So far, only few studies have been conducted with respect to 
HPP effect on human milk components (Molto-Puigmarti et al., 2011; Permanyer et al., 2010; 
Viazis et al., 2007). 
The objectives of the present study were to investigate HPP effects on IgA, IgM, IgG and 
the antibacterial enzymes lysozyme and lactoperoxidase, and to compare them with those of Holder 
pasteurisation. Pressure treatments of 200, 400 and 600 MPa for 2.5, 15 and 30 min at 8 ºC were 
carried out, in order to assess HPP effects at various pressure levels and holding times, thus, 
allowing an overview of HPP performance regarding these human milk proteins. Additionally, the 
effect of HPP at particularly high pressures combined with high temperatures (500, 700 and 900 
MPa at 40, 60 and 80 ºC for 15 min) in lysozyme activity was determined. This is the first study to 
determine the combined effect of temperature and pressure in human milk.  
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2. Material and methods 
The methods used in this chapter for immunoglobulin and enzyme activity analysis were 
the same as those used in Chapter 2 with some minor modifications; thereby in this chapter they 
will just be briefly explained. 
2.1.  Human milk samples 
Human milk samples were obtained from 7 healthy volunteer mothers 20-90 days after 
term delivery (mature human milk) at Infante D. Pedro Hospital in Aveiro, comprising a total 
volume of 150 mL. All the mothers gave their informed consent to participate in this study after 
receiving information about the aim and required procedures (Appendix A). The study was 
previously approved by the Hospital Ethical Committee. Exclusion criteria for the mothers were the 
following: a positive blood test result for HIV, HTLV, hepatitis B or C, or syphilis; use of illegal 
drugs, tobacco products, smoking, or excessive alcohol consumption; malnutrition; and recent 
infectious diseases. Human milk was collected into sterile polypropylene containers, by manual or 
mechanical expression of the breast, using a Swing electric breast pump for the mechanical 
expression provided by Medela (Medela, Portugal). After collection, human milk samples were 
immediately frozen in the hospital and then transported to the laboratory in ice and stored at -20 ºC. 
A few weeks later they were thawed in a water bath, pooled together, divided into aliquots and 
assigned to eleven different groups: one of untreated mature milk, one to be thermally pasteurised, 
and nine for the various HPP treatments (200, 400 and 600 MPa for 2.5, 15 and 30 min each). 
During the day of the treatments samples were kept in an ice bath and then frozen at -80 ºC and 
stored at -20 ºC up to two months until analysis. 
Frozen human milk samples used for the pressure treatments at high temperatures (500, 
700 and 900 MPa at 40, 60 and 80 ºC each) were provided by Instituto Tecnológico 
Agroalimentario de Extremadura (INTAEX, Badajoz, Spain) and all of these treatments were 
performed there. The samples were collected from Spanish mothers at 6 months postpartum. These 
samples were thawed on the day of the pressure treatments, kept in ice until processed, and frozen 
again at the end of the day at -80 ºC. The next day they were transported in ice boxes frozen to 
Aveiro, Portugal, and stored at -20 ºC for subsequent analysis. The analyses were performed in less 
than a month after freezing. 
2.2.  Thermal pasteurisation 
Thermal pasteurisation was carried out by mimicking the Holder method (62.5 ºC for 30 
min), according to the HMBANA procedure (Updegrove, 2005). Nine polypropylene tubes 
containing 1.5 mL of human milk each were placed in a water bath that was previously preheated 
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to 62.5 ºC. Another tube with the same amount of semi-skimmed cow’s milk was placed in the 
centre of them with a thermocouple in the middle as a control of the time that human milk would 
need to reach the desired temperature of 62.5 ºC. Once that temperature was reached, the samples 
were held in the water bath for 30 min. After pasteurisation, the tubes were quickly cooled in an ice 
slurry and immediately frozen at -80 ºC. 
2.3.  High-pressure processing 
The pressure treatments at 8 ºC were conducted using a hydrostatic press from Unipress 
Equipment, Model U33 (Warsaw, Poland), with a pressure vessel of 100 mL (35 mm diameter and 
100 mm height), surrounded by an external jacket, connected to a thermostatic bath to control the 
temperature. The unit has a maximum working pressure of 700 MPa and a working temperature 
between -20 ºC and 100 ºC. The pressure-transmitting fluid was a mixture of propylene glycol and 
water (60:40). Nine distinct treatments were performed: 200 MPa for 2.5, 15 and 30 min; 400 MPa 
for 2.5, 15 and 30 min; and 600 MPa for 2.5, 15 and 30 min. Time to reach the pressure was of 
0.75, 1.12 and 1.23 min for 200, 400 and 600 MPa, respectively, resulting in compression rates of 
264, 360 and 426 MPa/min. Before each pressure treatment, human milk was aliquoted to nine 
polypropylene tubes (1.5 mL each), which were inserted into a small flexible plastic bag that was 
vacuum-sealed, placed inside another plastic bag and sealed again, with caution not to leave air 
inside the two bags. 
For the pressure treatments combined with high temperatures, a thermostated multivessel 
high pressure equipment (Resato) was used. This equipment has a maximum working pressure and 
temperature of 1000 MPa and 100 ºC, respectively. Three different pressure levels were combined 
with three different temperatures: 500 MPa at 40, 60 and 80 ºC; 700 MPa at 40, 60 and 80 ºC; and 
900 MPa at 40, 60 and 80 ºC for 15 min. For the treatments, 10 mL of human milk were pipetted in 
two small flexible plastic bags per treatment, which were vacuum-sealed and inserted into another 
plastic bag. 
2.4.  Immunoglobulin analysis 
Total IgA, IgM and IgG were measured in human milk using Human IgA, IgM and IgG 
ELISA kits (KOMA BIOTECH), respectively, according to the manufacturer’s instructions. In all 
of the procedures, 100 µL of blank, standard or human milk samples were added to each well of the 
pre-coated microplate and incubated at room temperature for 1 h with the plate sealer provided. 
The standards were diluted following the manufacturer’s recommended dilutions and samples were 
diluted from 1:3000 to 1:5000, depending on the Ig. Then 100 µL of the diluted detection antibody 
(1:20000 to 1:50000) were added per well and incubated during 1 h at room temperature in the 
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sealed plate. Before, between and after the above steps the wells were aspirated to remove the 
liquid and washed five times with the washing solution to remove unbound molecules. For the 
color development reaction, 100 µL of color development solution were added to the wells and 
incubated for about 10 min for a proper color development. The reaction was stopped by adding 
100 µL of the stop solution and the absorbance read at 450 nm in less than 20 min using a 
Multiskan GO microplate reader (Thermo Scientific). Duplicate determinations were performed for 
each Ig, and total immunoglobulin concentrations were determined using the standard curves 
constructed with the diluted standards (Appendix B). 
2.5.  Antimicrobial enzyme activity analysis 
Lysozyme activity was determined using a Micrococcus lysodeikticus based turbidimetric 
assay recommended by Sigma Chemical Co. (Sigma, St. Louis, MO). Briefly, 2.50 mL of 0.015% 
(w/v) Micrococcus lysodeikticus cell suspension (substrate) at 30 ºC were mixed with 0.10 mL of 
diluted human milk and the absorbance at 450 nm (A450nm) was immediately recorded for 3 min. 
Measurements were carried out against the bank and each sample was measured in triplicate. The 
ΔA450nm/min was calculated from the slope of the linear part of the regression line when the 
absorbance decrease was plotted versus reaction time. One unit of lysozyme activity was defined as 
the amount of enzyme that produces a ΔA450nm/min of 0.001 per min at pH 6.24 at 30 ºC using a 
suspension of Micrococcus lysodeikticus as substrate, in a 2.6 mL reaction mixture. 
LPO activity was measured spectrophotometrically at 412 nm and 30 ºC with 2,2’-azino-di-
3-ethylbenzthiazoline-6-sulphonic acid (ABTS) in phosphate buffer (0.1 mM, pH 6.7) and 0.3 mM 
H2O2, according to the modified method of Pruitt and Kamau (1994). The reaction was monitored 
for 12 h. Each sample was analysed in triplicate and against the blank. 
2.6.  Statistical analysis 
Differences in the concentration of IgA, IgM and IgG, and in the activity of lysozyme 
between treated and untreated samples and between different treatments were assessed at a 0.05 
level of significance in a one-way analysis of variance (ANOVA), followed by a multiple 
comparisons test (Tukey’s HSD). The data are expressed as mean ± standard deviation, and the 
standard deviation was always < 15 %. 
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2.7.  Kinetic data analysis 
Isobaric denaturation of human milk IgM and IgG at 600 MPa could be described by a first 
order model (2), allowing the reaction rate constant (k) to be determined from a semilogarithmic 
plot (3) of the Ig retention (A/A0) as a function of treatment time (t). D-values (decimal reduction 
time) were also calculated according to (4). 
 
 
  
  
             (2) 
    
 
  
              (3) 
    
      
 
         (4) 
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3. Results and discussion 
3.1.  Effects of thermal pasteurisation and HPP on immunoglobulins 
As Holder pasteurisation of donor milk in HMB is a mandatory step to ensure microbial 
safety, but results in variable nutritional and non-nutritional losses, in the search for an alternative 
pasteurisation technology, HPP effects on human milk IgA, IgM and IgG contents for a wide range 
of pressures and holding times were determined. Holder pasteurisation was also tested with the aim 
of comparing the effects of both technologies. Table 10 presents IgA, IgM and IgG concentrations 
in raw and treated human milk. This data was also converted to percentages, considering 100 % the 
value obtained for raw human milk, and represented in Figure 9, in order to help establish 
comparisons between the distinct treatments effects. 
Table 10. IgA, IgM and IgG concentrations and lysozyme activity in mature human milk before and after 
Holder pasteurisation and the various HPP treatments. 
Treatment 
IgA concentration 
(mg/mL) 
IgM concentration 
(mg/mL) 
IgG concentration 
(mg/mL) 
Lysozyme 
activity (U/mL) 
Raw 0.826 ± 0.066 0.178 ± 0.010 0.048 ± 0.002 22453 ± 141 
Holder 0.606 ± 0.049 0.054 ± 0.001 0.035 ± 0.002 11180 ± 466 
200 MPa 2.5’ 0.837 ± 0.017 0.175 ± 0.006 0.046 ± 0.001 22933 ± 1546 
200 MPa 15’ 0.815 ± 0.033 0.174 ± 0.008 0.045 ± 0.003 24867 ± 599 
200 MPa 30’ 0.834 ± 0.051 0.174 ± 0.002 0.050 ± 0.002 21360 ± 682 
400 MPa 2.5’ 0.926 ± 0.059 0.169 ± 0.008 0.048 ± 0.002 21600 ± 1221 
400 MPa 15’ 0.828 ± 0.023 0.166 ± 0.004 0.055 ± 0.002 21500 ± 271 
400 MPa 30’ 0.817 ± 0.031 0.167 ± 0.003 0.046 ± 0.002 26573 ± 675 
600 MPa 2.5’ 0.945 ± 0.009 0.112 ± 0.001 0.048 ± 0.000 21247 ± 830 
600 MPa 15’ 0.588 ± 0.001 0.067 ± 0.005 0.035 ± 0.003 24720 ± 523 
600 MPa 30’ 0.567 ± 0.041 0.041 ± 0.000 0.033 ± 0.002 24053 ± 201 
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Figure 9. Percentage of IgA, IgM and IgG concentration in human milk before and after Holder 
pasteurisation and the various HPP treatments performed. Bars with the same letter are not statistically 
different (p<0.05).  
0 
20 
40 
60 
80 
100 
120 
140 
Ig
A
 c
o
n
ce
n
tr
at
io
n
 (
%
) 
IgA 
a a a a a a a a 
b 
b b 
0 
20 
40 
60 
80 
100 
120 
Ig
M
 c
o
n
ce
n
tr
at
io
n
 (
%
) 
IgM 
a a a a a a a 
b 
c cd d 
0 
20 
40 
60 
80 
100 
120 
140 
Ig
G
 c
o
n
ce
n
tr
at
io
n
 (
%
) 
IgG 
a 
ab ab b b ab b ab 
c c c 
CHAPTER 3. Human Milk 
 
 
 
71 
University of Aveiro – Chemistry Department 
 
3.1.1. IgA 
Total IgA concentration obtained for raw human milk in this study (Table 10) is among 
those reported by various other authors (Mickleson & Moriarty, 1982; Viazis et al., 2007; Weaver 
et al., 1998), even though there are some variations. Ford et al. (1977) and Permanyer et al. (2010) 
found slightly lower IgA concentrations of 0.5, and 0.247-0.488 mg/mL, respectively. This is 
understandable, once human milk composition varies over the course of lactation and between 
lactating women (Prentice et al., 1984), for example with the mother’s dietary habits and 
nutritional status (Garg et al., 1988). Holder pasteurisation caused a significant 27% decrease in 
human milk IgA content (p<0.05; Figure 9), which is consistent with the decreases found in other 
studies for mature milk (Czank et al., 2009; Ford et al., 1977; Permanyer et al., 2010) and in 
Chapter 2 for colostrum. 
IgA concentration in human milk was maintained after HPP treatments at 200 and 400 MPa 
for all holding times, and 600 MPa for 2.5 min (Figure 9). After 400 and 600 MPa for 2.5 min IgA 
content was increased in 12 and 14%, but these increases are not statistically significant (p>0.05). 
On the other hand, after 600 MPa for 15 and 30 min IgA retention was significantly decreased to 
71 and 69%, respectively (p<0.05). This is probably due to changes in the secondary structure of 
IgA, which lead to protein denaturation. As reviewed by Hendrickx et al. (1998), hydrogen bonds 
are responsible for maintaining the helical structure of peptides, and are enhanced at low pressures 
and ruptured at very high pressures. Likewise, the rupture of ionic bonds is strongly affected by 
pressure increases. The same explanation applies to IgM or IgG in human milk. 
The retention at 600 MPa for 15 and 30 min is similar to that of Holder pasteurised milk, 
and hence HPP treatments at 600 MPa for 15 min or more are no longer a better alternative to 
Holder pasteurisation in what concerns IgA retention. Also in the previous study with human 
colostrum (Chapter 2) this same behaviour was observed. In agreement with this, other authors 
reported 100% IgA maintenance after 400 MPa for 5 min at 12 ºC, and a decrease to 69% after 
HPP at 600 MPa for 5 min (Permanyer et al., 2010). Similarly, in this work it was verified that IgA 
content is retained after HPP at 400 MPa regardless of treatment times, and reduced to 71% after 
pressure processing at 600 MPa for 15 min. Besides, when crossing these data, it can be inferred 
that pressure processing at 600 MPa for short times might cause no significant differences in IgA 
content (as observed for 2.5 min) and may be a possible alternative to thermal pasteurisation as 
well. 
3.1.2. IgM and IgG 
After IgA, which is the major immunoglobulin present in human milk, IgM and IgG are the 
second and third main Igs. In this work, IgM and IgG mean concentrations in raw human milk were 
CHAPTER 3. Human Milk 
 
 
 
72 
University of Aveiro – Chemistry Department 
 
of 0.178 and 0.048 mg/mL, respectively (Table 10). IgM content is in accordance to that found by 
other authors for mature human milk (Ford et al., 1977; Shi et al., 2011), yet slightly higher, and is 
slightly lower than that determined for colostrum (Chapter 2). Nevertheless, this concentration is 
almost 4 and 6-fold higher than those determined by Mickleson and Moriarty (1982) for mature 
breast milk of women from New Zeland at 42 and 70 days postpartum, and similar to IgM 
concentration in milk at 14 days postpartum. IgG concentration, in its turn, is more similar to those 
found by these authors at 14, 42 and 70 days after delivery, and 4-fold lower than the mean IgG 
concentration found by Shi et al. (2011) for Chinese women. These last authors actually observed a 
higher concentration of IgG than IgM in human milk throughout lactation, which is uncommon. 
Some authors did not even detect IgG in human milk (Ford et al., 1977). 
After Holder pasteurisation IgM concentration was significantly reduced in 69% (p<0.05; 
Figure 9). Even though IgM concentration was greatly reduced after Holder pasteurisation, in other 
studies it was shown to be completely destroyed (Ford et al., 1977; Koenig et al., 2005). In the 
previous study with human colostrum (Chapter 2) a lower IgM reduction of about 51% was found. 
The several pressure treatments conducted resulted in less IgM losses than Holder pasteurisation 
(excepting for the one at 600 MPa for 30 min). HPP at 200 and 400 MPa for 2.5, 15 and 30 min did 
not cause significant reductions in IgM content (p>0.05; Figure 9). Nevertheless, after 600 MPa for 
2.5 min IgM content was significantly reduced to 63%. Moreover, the pressure treatments at 600 
MPa for 15 and 30 min led to significant IgM destruction of 63 and 77% (37 and 23% retention), 
respectively. These two last HPP treatments caused identical losses to Holder pasteurisation. When 
comparing to HPP effect on IgM of human colostrum (Chapter 2), these results are similar for 200 
and 400 MPa and are somewhat different for HPP at 600 MPa, since colostral IgM was less 
reduced after 2.5, 15 and 30 min at 600 MPa. 
Regarding IgG, its concentration was significantly decreased by 26% after Holder 
pasteurisation (p<0.05). IgG reduction of pasteurised milk in this work is in agreement with the 
34% reduction obtained by Evans et al. (1978) and the 23% reduction obtained for colostrum 
(Chapter 2). In contrast to pasteurisation, IgG was not significantly reduced after any of the 
treatments at 200 and 400 MPa, and 600 MPa for 2.5 min (p>0.05; Figure 9). After 400 MPa for 15 
min it was even increased in 16%, but this increase was not statistically significant. HPP at 600 
MPa for 15 and 30 min caused significant IgG reductions, of 27 and 31% (73 and 69% retention), 
respectively, which are not statistically different from those caused by thermal pasteurisation. 
These results are consistent with those reported for human colostrum (Chapter 2), except for the 
HPP treatments of 400 MPa for 15 min, that did not cause a significant increase in IgG content, and 
600 MPa for 2.5 min that led to a significant 21% IgG reduction. Overall, it was verified that also 
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for mature human milk HPP at 200 and 400 MPa up to 30 min maintains IgM and IgG much more 
effectively than the currently employed Holder pasteurisation. 
3.2.  Effects of thermal pasteurisation and HPP on antimicrobial enzyme activity 
Lysozyme and lactoperoxidase are the two most noted antimicrobial enzymes in milk, even 
though lysozyme is present in human milk in higher quantities than lactoperoxidase (Shahani et al., 
1980). Lysozyme activity in raw and treated samples was analysed and is presented in Table 10. 
Lysozyme activity retention (%) was also plotted in Figure 10 to help the comparison of these 
results. Lactoperoxidase activity is not presented, as no activity was found in quantifiable levels in 
any of the treated and untreated human milk samples for 12 h. In agreement with this, Ford et al. 
(1977) also did not detect lactoperoxidase activity in mature milk. Thus, in the future other assay 
methods with lower sensitivity limits should be tested. Anyway, it may be concluded that this 
enzyme has a low activity in the human milk used. Lysozyme activity in raw milk determined in 
this work (Table 10) is slightly higher than that of human colostrum (Chapter 2), which agrees with 
the reported fact that lysozyme activity does not decrease along lactation, as many other proteins 
and antimicrobial factors; instead it increases progressively throughout lactation (Prentice et al., 
1984). This activity is also similar to that presented by Viazis et al. (2007), if one considers the 
average protein content of human milk reported in literature (≈ 8-10 g/L) (Lönnerdal, 2003). 
It is well known that lysozyme content and activity decrease after thermal LTLT 
pasteurisation. Evans et al. (1978) found a 24% decrease in lysozyme content, while Czank et al. 
(2009) found a 61% destruction of lysozyme in mature human milk. In addition, Viazis et al. 
(2007) reported a 21% loss of activity after Holder pasteurisation. A much higher 50% loss of 
activity was obtained in this work, as represented in Figure 10. This significant loss (p<0.05) is 
consistent with that found in human colostrum after pasteurisation, of 44% (Chapter 2).  
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Figure 10. Percentage of lysozyme activity in human milk before and after Holder pasteurisation and the 
various HPP treatments performed. Bars with the same letter are not statistically different (p<0.05). 
None of the pressure treatments caused significant reductions in lysozyme activity. On the 
contrary, pressure treatments at 200 MPa for 15 min, 400 MPa for 30 min and 600 MPa for 15 min 
led to significant 11, 18 and 10% increases in this enzyme activity, respectively (p<0.05; Figure 
10). This lysozyme activity retention pattern after HPP was also found for colostrum (Chapter 2) 
and had already been demonstrated by Viazis et al. (2007) at 400 MPa up to 120 min. After 400 
MPa for 30 min these authors also observed an increase in lysozyme activity (of 7%), even though 
it was not significant. Besides, Tedford et al. (1999) reported that bovine milk lysozyme was 
relatively pressure-resistant, with small structural modifications after HPP up to 600 MPa and 30 
min. The increase in enzyme activity after HPP was reported by various authors for other enzymes 
as well, so a few examples will be presented. Pressure-induced activation of pectin methyl esterase 
(PME) in orange juice was achieved after HPP at 200-400 MPa at room temperature (Cano et al., 
1997). The activation of polyphenoloxidase activity in pears at 400-600 MPa at 20 ºC was also 
reported (Asaka et al., 1994). Moreover, polygalacturonase activity was increased after diced 
tomatoes were pressurized at 400 MPa for 5 min at 25 ºC (Shook et al., 2001), but the activity 
decreased increasing processing time and pressure. 
In the present study, a maintenance or increase in lysozyme activity was observed for the 
wide range of pressures tested. The increase in its biological activity may be explained by the 
occurrence of conformational changes (Asaka et al., 1994) or high pressure dissociation of 
lysozyme aggregates, making the enzyme more available of exerting its activity (Seefeldt et al., 
2009). These results are very interesting, once lysozyme maintenance in human milk may help 
protect the infants against bacterial infections and also contribute to microbial safety of human milk 
for increased periods. 
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3.3.  HPP denaturation kinetics of human milk immunoglobulins 
Unlike what was verified for human colostrum (Chapter 2), in human milk only HPP 
denaturation of IgM and IgG could be described by a first order kinetic model (Appendix E), after 
reaction kinetic analysis of all Igs. Regarding IgA, none of the pressure treatments allowed the 
establishment of a linear decreasing tendency in IgA retention (A/A0) for the treatment times 
studied (more times should be studied in the first 15 min). For IgM and IgG, linear decreases were 
found just for the pressure treatment at 600 MPa. In these last cases, denaturation kinetic 
parameters k (reaction rate constant) and D (decimal reduction time) were calculated and are 
presented in Table 11. Besides, due to the limited treatment times studied, this is a preliminary 
determination of k and D-values. More treatment times have to be studied in order to further refine 
these values. 
Table 11. Kinetic parameters for HPP denaturation of IgM and IgG in human milk, assuming a first order 
reaction. 
Immunoglobulin Pressure (MPa) k-value (min
-1
) r
2
 D-value (min) 
IgM 600 4.49  10-2 0.936 51 
IgG 600 1.32  10-2 0.814 174 
 
Coefficients of correlation (r
2
) are not very high, but are among those reported in literature 
for this type of analysis (Ludikhuyze et al., 2001). D-value of IgM is much lower (more than 3-
fold) than that of IgG, showing the higher pressure sensitivity of IgM. This is in agreement to what 
was found for human colostrum (Chapter 2). In addition, IgM D-value at 600 MPa for human milk 
was similar to the same value for human colostrum (40 min). IgG D-value, in its turn, is lower than 
that found for human colostrum. This value is more close, yet superior, to that reported by Mazri et 
al. (2012) for bovine milk. As far as the authors are aware, this is the first study of high pressure 
denaturation of IgM and IgG in human milk, and there are not any in human colostrum, as well. 
Similarly to what was verified for human colostrum, it seems that denaturation may occur more 
rapidly in the first 15 min of pressure exposure and more slowly after that period of time (biphasic 
denaturation pattern). Nevertheless, more treatment times in the studied range (0-30 min) and in an 
extended range (e.g. up to 120 min) should be tested in order confirm these preliminary 
assumptions. 
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3.4.  Effects of high pressure combined with high temperature on lysozyme activity 
As it was observed that lysozyme was pressure-resistant to pressures up to 600 MPa for 30 
min at 8 ºC (Table 10, Figure 10), its resistance to high pressure levels combined with high 
temperatures was tested, and the results are presented in Figure 11 (see Appendix F for lysozyme 
activity values). Pressure treatments of 500, 700 and 900 MPa at 40, 60 and 80 ºC for 15 min were 
performed. Raw milk had a lysozyme activity of 28553 U/mL, which is a little higher than that 
found for human milk collected from Portuguese women (Table 10). Even though this human milk 
came from different mothers, the reason for the higher lysozyme concentration may be that this 
human milk was collected later in lactation, at 6 months. 
 
Figure 11. Percentage of lysozyme activity in human milk before and after 15 min exposure to the high 
temperatures and the HPP treatments performed. Bars with the same letter are not statistically different 
(p<0.05). 
The exposure to 40 and 60 ºC did not cause significant differences in lysozyme activity in 
relation to raw human milk (p>0.05, Figure 11). Nevertheless, a 15 min exposure to 80 ºC led to a 
92% loss of this enzyme activity (8% retention). This is in agreement with the fact that lysozyme 
reaches a maximum activity around 50 ºC, and is greatly decreased at 80 ºC (Hayashi et al., 1968). 
After the pressure treatments at 40 ºC (500, 700 and 900 MPa) lysozyme activity significantly 
increased to 143, 150 and 116, respectively. This pattern of enzyme activity increase at high 
temperatures has been reported in literature for other enzymes. For instance, Shook et al. (2001) 
noted that pectinesterase activity in diced tomato was increased after 400 MPa at 45 ºC for 5 min, 
and Van Den Broeck et al. (2000) found that at low pressures and elevated temperatures (100-300 
MPa and 60-65 ºC) there was an activation of tomato PME. In this work, after 500 and 700 MPa at 
60 ºC lysozyme activity was not significantly inactivated (p>0.05). However, when increasing the 
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pressure level to 900 MPa lysozyme activity fell to 74% (26% loss), which is a significant 
decrease. HPP at 500, 700 and 900 MPa at 80 ºC reduced lysozyme activity to residual levels 
(about 0.4%), that is, resulted in almost total inactivation. 
In short, pressure treatments at 500, 700 and 900 MPa at 40 ºC increase lysozyme activity 
in human milk, mostly pressure levels of 500 and 700 MPa. Therefore, it can be asserted that the 
combined effect of high pressures and moderate temperature effectively increases lysozyme 
activity. However, the same pressure levels at 60 ºC do not exert that effect anymore. HPP at 900 
MPa at 60 ºC even causes a significant reduction in its activity. HPP at 80 ºC completely 
inactivates lysozyme.  
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4. Conclusions 
In agreement with what we had reported for human colostrum, IgA content in mature 
human milk is retained after HPP at 200 and 400 MPa for all holding times, and 600 MPa for 2.5 
min. These same treatments are also effective in maintaining IgG concentration. On the other hand, 
HPP treatments at 600 MPa for 15 and 30 min, and Holder pasteurisation resulted in similar 
significant decreases of these Igs (up to 31% for both). IgM, in its turn, was not significantly 
decreased after 200 and 400 MPa for 2.5, 15 and 30 min. Nevertheless, a significant 37% decrease 
after 600 MPa for 2.5 min was observed. Still, this decrease is much lower than that caused by 
Holder pasteurisation, of 69%. HPP at 600 MPa for 15 and 30 min caused marked decreases, which 
were not significantly different from those resulting of pasteurisation treatment. 
Regarding antimicrobial enzymes, lactoperoxidase activity was not found. Lysozyme 
activity was significantly decreased to 50% after Holder pasteurisation, but maintained or increased 
after all of the HPP treatments at 8 ºC. Treatments of 200 MPa for 15 min, 400 MPa for 30 min, 
and 600 MPa for 15 min led to 111, 118 and 110% retentions, which suggests that some pressure 
levels and holding times may cause lysozyme activation. When combining HPP with high 
temperatures, we observed that after 500, 700 and 900 MPa at 40 ºC lysozyme activity was also 
significantly increased to 143, 150 and 116%, respectively. The increases at 500 and 700 MPa at 40 
ºC are the highest found in this work. After 500 and 700 MPa at 60 ºC its activity was not 
significantly different from that of raw milk, but 900 MPa at 60 ºC already caused a significant 
26% inactivation. After HPP at 80 ºC the enzyme was almost completely inactivated, and only 
presented residual activity. 
These findings indicate that not only HPP treatments at 200 and 400 MPa up to 30 min are 
a better alternative to Holder pasteurisation in terms of Ig and lysozyme retention, that also some of 
these treatments may induce an increase in the available Ig content and lysozyme activity in human 
milk. HPP treatments at 500, 700 and 900 MPa at 40 ºC proved to be effective in activating 
lysozyme, as well. Thus, other studies should be conducted in order to determine HPP effects in 
other nutritional and non-nutritional human milk components. 
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CHAPTER 4 
General Conclusions and Future work: A Synopsis of Future Requirements 
The immunological and functional benefits that only human milk provides to infants have 
led to an increased interest in banked donor human milk. Nowadays, there is no doubt left that 
donor human milk is definitely a better choice than cow’s milk-based infant formulas. However, 
the pasteurisation method that is currently applied to assure the safety of donor milk provided by 
HMB is far from being ideal. Holder pasteurisation is responsible for considerable decreases in the 
antimicrobial and functional biomolecules that make human milk the optimum nutritional source 
for infants. Therefore, to study other pasteurisation technologies that simultaneously minimise 
microbial contaminants and maintain these factors is critical for the development of safe effective 
milk banking procedures. HPP is par excellence one of those technologies and, probably, the most 
promising one. 
HPP is, however, in a very premature stage of investigation in what concerns human milk 
pasteurisation and preservation, and few studies have been conducted so far (Table 7). In the 
present work a comprehensive review of human milk composition and preservation in HMB, as 
well as HPP principles, operation and reported effects in human milk was carried out in order to 
help understand what is already known and the best way to apply this promising pasteurisation 
technology to such a valuable food. Furthermore, this work evaluated HPP effects on IgA, IgM, 
and IgG contents, and lysozyme activity in human colostrum and milk, as lactoperoxidase activity 
was not detected. It was concluded that, when comparing HPP with Holder pasteurisation, HPP at 
200 and 400 MPa resulted in much higher retentions of these antimicrobial factors in human 
colostrum and milk. In almost all of the components there were no significant differences between 
pressure processed and raw human milk samples (excepting IgM in mature milk after 400 MPa for 
15 and 30 min), while Holder pasteurisation always caused significant decreases. These results 
show the great potential of HPP to be used in HMB. 
Notwithstanding, there is still a long path to be taken before HPP can be developed into a 
successful pasteurisation technology for human milk. Regarding human milk components, HPP 
effects in the overall nutritional composition have to be assessed. It is essential to study HPP 
effects in human milk lipids, as well as fatty acid profile; whey proteins and casein; carbohydrates 
in general (mainly lactose) and oligosaccharides in particular, as they have important bioactive 
functions. Besides, its effects on vitamins and minerals also have to be determined. HPP will only 
be a viable alternative if high pressure does not affect these nutritional components. Further work 
should also focus on investigating HPP effects on other bioactive and immune factors (namely 
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those decreased by Holder pasteurisation), such as lactoferrin, both lipases (BSSL and LPL), 
amylase, lymphocytes, cytokines and growth factors. 
In what concerns human milk contamination with microorganisms, research is needed to 
evaluate HPP capacity to effectively inactivate relevant bacterial and viral pathogens. Even though 
some work has been done for determining HPP effects on some vegetative bacteria with interesting 
results, more studies are required to establish recommended processing times that result in 
satisfactory inactivation of all relevant pathogens, and maintain human milk natural composition. 
For example, studies of HPP inactivation of bacteria in the bacillus species, as Bacillus cereus, are 
fundamental. Studies on viral pathogens are essential as well, and possible viral pathogens to study 
include HIV, HTLV, polivirus, herpes simplex virus, hepatitis A, and cytomegalovirus. Moreover, 
antimicrobial compounds present in human milk should be further investigated in combination with 
HPP to clarify a possible synergy that promotes higher inactivation of pathogens. 
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Appendix A. Informed consent given to all of the participant mothers. 
 
CONSENTIMENTO INFORMADO, LIVRE E ESCLARECIDO PARA 
PARTICIPAÇÃO EM PROJETO DE INVESTIGAÇÃO 
 
O meu nome é Maria Sílvia Gomes de Sousa e estou a realizar a minha tese de Mestrado em 
Biotecnologia, ramo Alimentar, inserida num grupo de investigação do Departamento de Química 
da Universidade de Aveiro, sendo orientada pelo Prof. Dr. Jorge Manuel Alexandre Saraiva, 
professor na mesma instituição de ensino. Estamos a desenvolver um projeto intitulado “Efeito da 
alta pressão em leite e colostro humanos com vista à sua pasteurização atérmica/a frio” que visa 
o estudo de um novo método de pasteurização do leite materno – a alta pressão – que permite 
melhor conservar o seu valor nutricional comparativamente àquele usado atualmente em bancos 
de leite materno – a pasteurização térmica –. 
 
Para desenvolver este método alternativo de pasteurização atérmica por alta pressão, o qual 
garante a segurança microbiológica do leite materno com maior manutenção das suas 
propriedades nutricionais, solicitamos a sua participação no estudo através da doação do leite ou 
colostro que não necessite para a nutrição do seu bebé, agradecendo desde já a colaboração. 
Abaixo esclarecem-se algumas questões bastante pertinentes: 
Porquê? Os bancos de leite humano são de extrema importância para as mães que, por alguma 
razão, não podem amamentar ou não possuem leite suficiente para suprir as necessidades do seu 
bebé, uma vez que este apresenta benefícios imunológicos e nutricionais acrescidos 
relativamente às fórmulas infantis à base de leite de vaca, diminuindo consideravelmente o risco 
de ocorrência de infeções e diversas doenças crónicas. O método de pasteurização térmica 
comummente usado garante a segurança microbiológica do leite, mas produz um leite “cozido” 
com características nutricionais e funcionais diminuídas em relação ao leite “cru” não 
pasteurizado, bem como alterações nas propriedades sensoriais. Assim, o leite de mães dadoras 
pasteurizado não é suficiente para garantir a satisfação das necessidades nutricionais e 
imunológicas dos bebés, principalmente daqueles nascidos prematuramente, doentes ou com 
peso muito baixo, os quais apresentam maiores carências nutricionais. É então fulcral a evolução 
dos estudos de pasteurização atérmica do leite e colostro humanos, alimentos essenciais ao 
saudável crescimento e desenvolvimento dos bebés. 
Procedimentos? Será realizada a recolha de amostras de leite materno de acordo com as 
seguintes etapas: 
1) Pedido de consentimento informado, livre e esclarecido para a participação neste 
projeto de investigação. É indispensável o consentimento de todas as mães participantes 
para a recolha do seu leite. 
 
 
 
III 
University of Aveiro – Chemistry Department 
 
2) Extração do leite materno através do uso de bombas adequadas para esse fim, recolha 
do mesmo para frascos estéreis de plástico e preenchimento da ficha de registo da(s) 
data(s) de recolha do leite. Esta etapa do processo será realizada pelas mães 
preferencialmente e sempre que possível no hospital ou então em casa. 
 
Riscos? Não existem quaisquer riscos ou ameaças à integridade física ou emocional das 
participantes. A extração do leite é segura, indolor e não se conhecem efeitos secundários. 
Benefícios? A oportunidade de colaborar num projeto pioneiro de estudo de uma nova e 
promissora tecnologia de pasteurização atérmica que pode melhorar consideravelmente a 
qualidade nutricional e sensorial do leite de mães dadoras disponível nos bancos de leite humano, 
ajudando muitos bebés. Todas as mães participantes terão acesso aos resultados e conclusões do 
projeto, caso assim o desejem. 
Alternativas? A participação no projeto através da doação de leite materno é voluntária, podendo 
solicitar todos os esclarecimentos que considere necessários. Para participar apenas tem de 
efectuar os procedimentos descritos acima. Tem igualmente a opção de não participar ou 
interromper a participação em qualquer altura, não sendo adotados quaisquer procedimentos 
discriminatórios na sua assistência nesta Unidade de Saúde. 
Dúvidas? Qualquer dúvida que surja pode e deve ser colocada em qualquer altura através do meu 
contacto telefónico ou e-mail, 917605872 e silviasousa@ua.pt, respetivamente. Abaixo 
esclarecem-se algumas dúvidas frequentes: 
- A sua participação não lhe trará nenhum tipo de custos; 
- O leite doado será usado exclusivamente no âmbito deste projeto de investigação; 
- É garantida confidencialidade, sendo que todos os dados das mães participantes serão apenas 
conhecidos pela equipa médica e de investigação; 
- Os resultados do estudo serão publicados em revista científica e na minha tese de Mestrado. 
 
[ver continuação na página seguinte deste documento] 
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Confirmo que expliquei à pessoa abaixo indicada, de forma adequada e inteligível, os 
procedimentos necessários ao ato referido nas páginas 1 e 2 deste documento. Respondi a 
todas as questões que me foram colocadas e assegurei-me de que houve um período de 
reflexão suficiente para a tomada da decisão. Também garanti que, em caso de recusa, não 
serão adotados quaisquer procedimentos discriminatórios no contexto da sua assistência nesta 
Unidade de Saúde. 
O pedido de assinatura deste documento resulta do disposto na Circular Normativa nº 2 
/DSMIA de 15/01/2007, da Direção-Geral da Saúde. 
Nome legível do/a médico/a ou investigador/a: |____________________________________| 
Data … …/… …/… … … Assinatura … … … … … … … … … … … … … … … … … … … … … …. 
-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+- 
Por favor, leia com atenção todo o conteúdo deste documento. Não hesite em solicitar mais 
informações se não estiver completamente esclarecida. Verifique se todas as informações 
estão corretas. Se tudo estiver conforme, então assine este documento. 
 
“Declaro que concordo com a doação do meu leite materno conforme me foi proposto e explicado 
pela pessoa que assina este documento (para além de mim), conhecendo o seu fim, 
procedimentos a seguir, riscos, benefícios e alternativas e tendo podido fazer todas as perguntas 
sobre o assunto. Assim, autorizo a realização do ato indicado nas condições em que me foram 
explicadas e constam deste documento.” 
… … … … … … … … … … (local), … …/… …/… … … (data) 
Nome: |_______________________________________________________| 
Assinatura  … … … … … … … … … … … … … … … … … … … … … … … … … … … … 
Se não for a própria a assinar por incapacidade comprovada ou idade abaixo de 16 anos: 
Nome: ....................................................................................................................... 
B.I./C.C. Nº: ........................................... datado de ...../...../......, validade …../..…/…... 
Grau de parentesco ou tipo de representação: ........................................................ 
Assinatura  … … … … … … … … … … … … … … … … … … … … … … … … … … … … 
 
Referências: 
Documento-Guia sobre Consentimento Informado 
http://portal.arsnorte.min-
saude.pt/portal/page/portal/ARSNorte/Comiss%C3%A3o%20de%20%C3%89tica/Ficheiros/Consentimento_Informado_
Doc_Guia.pdf 
Modelos de Consentimento Informado 
http://portal.arsnorte.min-
saude.pt/portal/page/portal/ARSNorte/Comiss%C3%A3o%20de%20%C3%89tica/Ficheiros/Consentimento%20Informad
o/7A4D4ADDB2579BA4E040140A110272B3 
Muito obrigada pela participação! 
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Appendix B. Standard curves constructed for the determination of immunoglobulins in human 
colostrum and mature milk. 
 
 
Figure B1. Standard curve used for determining IgA concentration in human colostrum and mature milk. 
 
 
Figure B2. Standard curve used for determining IgM concentration in human colostrum and mature milk. 
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Figure B3. Standard curve used for determining IgG concentration in human colostrum and mature milk. 
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Appendix C. Immunoglobulin concentration and lysozyme activity in raw and treated colostrum 
samples. 
 
Table C1. Colostral IgA, IgM and IgG concentrations and lysozyme activity before and after Holder 
pasteurisation and the various HPP treatments. 
Treatment 
IgA concentration 
(mg/mL) 
IgM concentration 
(mg/mL) 
IgG concentration 
(mg/mL) 
Lysozyme 
activity (U/mL) 
Raw 1.728 ± 0.034 0.200 ± 0.011 0.199 ± 0.010 18033 ± 570 
Holder 1.383 ± 0.026 0.098 ± 0.002 0.152 ± 0.001 10127 ± 286 
200 MPa 2.5’ 1.701 ± 0.063 0.201 ± 0.006 0.193 ± 0.003 18040 ± 0 
200 MPa 15’ 1.740 ± 0.082 0.196 ± 0.017 0.207 ± 0.001 16667 ± 726 
200 MPa 30’ 1.733 ± 0.015 0.219 ± 0.017 0.180 ± 0.004 17020 ± 632 
400 MPa 2.5’ 1.782 ± 0.006 0.215 ± 0.007 0.184 ± 0.001 18687 ± 1588 
400 MPa 15’ 1.739 ± 0.007 0.201 ± 0.008 0.182 ± 0.006 16720 ± 635 
400 MPa 30’ 1.722 ±0.053 0.187 ± 0.013 0.182 ± 0.004 18900 ± 311 
600 MPa 2.5’ 1.669 ± 0.064 0.157 ± 0.003 0.157 ± 0.008 18460 ± 0.728 
600 MPa 15’ 1.388 ± 0.022 0.081 ± 0.001 0.129 ± 0.004 17580 ± 347 
600 MPa 30’ 1.284 ± 0.000 0.080 ± 0.004 0.120 ± 0.010 18080 ± 673 
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Appendix D. First order kinetic denaturation of human colostrum immunoglobulins. 
 
 
Figure D1. Effect of pressure treatment on human colostrum IgA concentration (A/A0) as a function of 
treatment time at different pressures: 200 MPa (), 400 MPa (), 600 MPa (). 
 
 
Figure D2. Effect of pressure treatment on human colostrum IgM concentration (A/A0) as a function of 
treatment time at different pressures: 200 MPa (), 400 MPa (), 600 MPa (). 
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Figure D3. Effect of pressure treatment on human colostrum IgG concentration (A/A0) as a function of 
treatment time at different pressures: 200 MPa (), 400 MPa (), 600 MPa (). 
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Appendix E. First order kinetic denaturation of human milk immunoglobulins. 
 
 
Figure E1. Effect of pressure treatment on human milk IgA concentration (A/A0) as a function of treatment 
time at different pressures: 200 MPa (), 400 MPa (), 600 MPa (). 
 
 
Figure E2. Effect of pressure treatment on human milk IgM concentration (A/A0) as a function of treatment 
time at different pressures: 200 MPa (), 400 MPa (), 600 MPa (). 
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Figure E3. Effect of pressure treatment on human milk IgG concentration (A/A0) as a function of treatment 
time at different pressures: 200 MPa (), 400 MPa (), 600 MPa (). 
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Appendix F. Lysozyme activity in raw and processed human milk samples (HPP at high 
temperatures). 
 
Table F 1. Lysozyme activity in human milk before and after 15 min exposure to the high temperatures and 
HPP treatments performed. 
Treatment Lysozyme activity (U/mL) 
Raw 28553 ± 1428 
40 ºC 30820 ± 780 
60 ºC 30397 ± 613 
80 ºC 2290 ± 306 
500 MPa 40 ºC 40813 ± 1641 
500 MPa 60 ºC 26040 ± 1054 
500 MPa 80 ºC 118 ± 4 
700 MPa 40 ºC 42807 ± 1192 
700 MPa 60 ºC 26627 ± 1227 
700 MPa 80 ºC 105 ± 7 
900 MPa 40 ºC 33040 ± 584 
900 MPa 60 ºC 21000 ± 209 
900 MPa 80 ºC 77 ± 3 
 
